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Summary 
Human brain is comprised of various types of cells, including neural stem 
cells (NSCs), fate-committed progenitors and differentiated cells. The 
diversity of cell types and the connections between them contribute to the high 
degree of complexity of the brain. Dysregulations in NSCs proliferation and 
differentiation, as well as in the growth of neurons and astrocytes may impair 
the normal development and result in neurological diseases, such as dementia. 
As both structural components and bioactive signaling molecules, lipids play 
crucial roles during the neural development. 
In this study, high performance liquid chromatography coupled to mass 
spectrometry was employed to obtain the lipid profiles at a comprehensive 
systematic level of NSCs, neurons at different developmental stages and 
astrocytes based on in vitro embryonic mice brain cell culture; the white and 
grey matter from the subcortical ischemic vascular dementia (SIVD) and 
Alzheimer’s disease-SIVD mixed dementia (MIX) patients brain with age-
matched controls. More than 150 individual lipid species from distinct 
subclasses were analyzed, including phospholipids, sphingolipids, and neutral 
lipids. 
The comprehensive lipidomics study reveals the lipid composition and 
metabolism of NSCs and differentiated neural cells at a systematic level for 
the first time. Results suggest that redox state, modulated by fatty acyl 
unsaturation, plasmalogen and lipid oxidation, is involved in the proliferation 
of NSCs and differentiated neural cells. Together with several bioactive 
sphingolipids (e.g. ceramide), redox state could modulate the switch between 
self-renewal and differentiation in NSCs, and potentially accommodate the 
higher proliferative ability of astrocytes against oxidative stress compared 
with neurons. Besides, differentially regulated membrane lipids possibly affect 
the structure of plasma membranes and intracellular vesicle-mediated 
trafficking, and may consequently influence its far-reaching cellular signaling 
and biochemistry during the proliferation and differentiation in NSCs, as well 
as the sequential neuronal growth. On the other hand, detailed lipid profiles in 
brain tissues from the SIVD and MIX patients implied that sphingolipid and 
phospholipid anomalies essentially underlie early pathogenic events of SIVD. 
  vii 
Molecular profiles highlighted the pathological relevance of sphingolipid fatty 
acyl chain heterogeneity, and identified sulfatide accumulation in the grey 
matter of temporal cortex, which could likely be attributed to the synergistic 
interactions between vascular and neuropathological lesions co-occurring 
specifically in MIX, as a possible marker that could distinguish pure 
Alzheimer’s disease from MIX. In addition, the correlation between lipid 
profiles on the cellular basis (NSCs and differentiated cells) and under 
pathological conditions (SIVD and MIX) would confer new insights 
pertaining to the pathogenesis of dementia at the cellular level.  
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1. Introduction 
1.1 Self-renewal and differentiation of neural stem cells (NSCs) 
The development of the human brain begins at the very early embryonic 
developmental stage, and the further process or regeneration continues over 
the course of human life. This complex organ is comprised of a variety of 
cells, including neural stem cells (NSCs), neuronal progenitor cells (NPCs), 
glial progenitor cells (GPCs), different types of neurons and glial cells. The 
diversity of cell types and the connections between them contribute to a high 
degree of complexity that is far greater than other organs in the human body. 
NSCs are self-renewing multipotent cells that are required for neurogenesis 
during normal neural development, homeostasis and under pathological 
conditions/traumatic injury (Figure 1-1) [1]. It was believed that neurogenesis 
is completed in prenatal and early postnatal developmental stages, and this 
process does not continue in the adult mammalian brain. However, new born 
neurons were found in the adult brain for the first time in 1912 [2] and 
accumulative evidence subsequently indicated that neurogenesis occurs in 
both embryonic and adult brains. NSCs expand the stem cell population 
through symmetric divisions before neurogenesis or gliogenesis starts; when 
the differentiation processes commence, NSCs divide asymmetrically to 
generate daughter stem cells and progenitors, which also undergo both 
symmetric and asymmetric cell divisions [3, 4]. 
The switch between proliferation and differentiation in NSCs, which is 
executed by either symmetric or asymmetric division, is crucial in neural 
development [5]. Cell polarity is an important factor to determine symmetric 
or asymmetric division in mammalians [6]. NSCs can be divided into two 
groups in terms of morphologies and functions. The first group consists of 
quiescent NSCs that seldom divide, and is referred to as apical precursors 
since mitosis occurs at the apical surface and cells connect to each other by 
adherent junctions in plasma membranes at the apical end [5].  Therefore, 
plasma membrane composition such as membrane lipids might regulate the 
cell division in these cells. The second group of NSCs is amplifying daughter 
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cells that are generated by apical precursors through asymmetric division and 
have higher mitotic activities, appearing at the onset of neurogenesis [7]. The 
intermediate precursor cells are referred to as basal precursors. Most of the 
basal precursors are capable of producing two identical neurons by symmetric 
division [8], while few of them have the ability of self-renewal [9]. 
 
1.1.1 Self-renewal of NSCs 
Self-renewal is a proliferation process to keep NSCs in an undifferentiated 
state. NSCs go through rounds of mitosis before committed to particular 
neural cell fates (Figure 1-1). This process is regulated by various intrinsic and 
extrinsic factors [10]. The microenvironment in vivo named as NSCs niche is 
composed of extracellular matrix, signaling molecules and surrounded cells, 
such as glial cells, endothelial cells, and neurons at different growth stages. 
The intracellular interaction and coordination between NSCs and the niche 
comprise the modulating network of NSCs self-renewal and differentiation 
[11, 12]. Increasing evidence reveals the importance of transcriptional 
regulators in maintaining the self-renewal of NSCs. Members of SRY-related 
HMG box (SOX) family (e.g. Sox2) are broadly expressed in proliferative 
NSCs [13]. Sox2 is essential for maintaining the self-renewal of NSCs, as the 
overexpression of Sox2 suppresses the neuronal differentiation and the cells 
remain undifferentiated [14]. Some nuclear receptors are also involved in 
regulating NSCs proliferation, such as estrogen receptor, thyroid hormone 
receptor [15, 16], peroxisome proliferator-activated receptor # (PPAR#) 
related with STAT3 [17], orphan nuclear receptor TLX [18], multiple basic 
helix-loop-helix (bHLH) genes [19], and polycomb family transcriptional 
repressor Bmil [20]. 
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Figure 1-1. Neurogenesis in the adult brain (adapted from [21-23]). Neurogenesis occurs 
in two regions in mammalian brains: subventricular zone (SVZ) residing at the lateral 
ventricles, and subgranular zone (SGZ), which is a part of the dentate gyrus in hippocampus. 
NSCs can self-renew to generate daughter stem cells and differentiate into neurons, astrocytes 
and oligodendrocytes. Neurons further go through several developmental stages and 
sequentially form the mature neuronal network. 
 
1.1.2 Differentiation of NSCs 
NSCs can differentiate into fate specific neural cells, including neurons and 
glial cells. Adult neurogenesis recapitulates the process of embryonic 
neurogenesis. Neurogenesis occurs in two regions in mammalian brain: 
subventricular zone (SVZ) residing at the lateral ventricles, and subgranular 
zone (SGZ), which is a part of the dentate gyrus in hippocampus [24] (Figure 
1-1). In SVZ, quiescent NSCs divide into transient amplifying cells, and 
sequentially give rise to neuroblasts. Neuroblasts migrate and differentiate into 
various subtypes of neurons [25]. Similarly in SGZ, quiescent NSCs seldom 
divide, but they can give rise to one daughter stem cell and one neuronal 




Neural stem cell Progenitor cells 
Self-renewal 
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Those daughter stem cells widely expressing nestin and Sox2 are considered 
as amplifying progenitors due to the high activities of mitosis [27]. On the 
other hand, the other fate-committed progenitors generated by SGZ NSCs via 
asymmetric divisions express the polysiliated form of the neural cell adhesion 
molecule (PSA-NCAM) instead of Sox2 or nestin [28]. Sequentially, neurons 
are generated by these amplifying neuronal progenitors through postmitotic 
differentiation [28]. Although there are differences of neurogenesis in SVZ 
and SGZ, similarities cover many features during general processes, such as 
components of niche, signaling pathways involved, temporal sequence of 
neurogenic process. Besides these two classical neurogenic regions, 
neurogenesis has been found in the cortex [29], amygadala [30], hypothalamus 
[31] and substantial nigra [32]. Recent evidence revealed that certain types of 
glial cells have the similar multipotent potential as NSCs. Radial glial cells in 
SVZ can give rise to radial glial cells, intermediate progenitor cells and 
neurons [33, 34]. Besides, both neurons and glial cells can be generated by 
astrocytes-derived neurospheres [35]. These new findings enrich the 
knowledge about neural development despite the existence of neurogenesis in 
these areas is still in debate. 
Neuronal maturation starts with the generation of the axon and dendrite. After 
a period of rapid axon elongation, the connections between axon and target 
region are established [36]. Dendritic growth happens before or concurrently 
when axon touches the target regions [37]. The initial dendrite formation starts 
with the apical dendrites exhibiting specific structures (e.g. growth cones, 
varicosities and filopodia) due to their immature nature, which can be 
observed within the first few postnatal days. This progress is followed by the 
basal dendrite generation, keeping pace with the further apical dendrite 
elongation and expansion. It is believed that branch additions in axons and 
dendrites occur concurrently with the retractions [38]. In a week time, the 
entire tree-like dendritic structure will be accomplished (Figure 1-1). 
Another group of differentiated cells derived from NSCs is the glial cell 
(Figure 1-1). Multipotent NSCs generate glial-fate committed intermediate 
precursors, which eventually give rise to differentiated astrocytes and 
oligodendrocytes. Different types of glial precursors have been identified, 
including tripotential precursors that have the ability to self-renewal, and 
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generate oligodendrocytes and astrocytes [39, 40], bipotential precursors that 
generate oligodendrocytes and astrocytes [41, 42], and unipotent precursors 
that give rise to astrocytes only [43-45]. Oligodendrocyte precursors are 
thought to arise in the ventricular zone and migrate to targeted regions. Once 
the migration ceases, differentiation and further maturation occur, such as 
expressing specific cell markers and adapting cell morphology to expand 
endfeet on axons in the brain [46]. Oligodendrocytes are essential for 
generating myelin sheath around the axons in white matter [47]. They are 
terminally differentiated, and the regeneration is strongly dependent on the 
precursors. Labeled by glial fibrillary acidic protein (GFAP), astrocyte is a 
group of abundant glial cells in the brain. This glial cell has diverse functions. 
They are believed to be a crucial structural component in the brain, providing 
growth factors and cytokines to neurons. Astrocytes are present in both grey 
and white matter.  The generation of astrocytes is continuing throughout the 
lifetime, and more abundant astrocytes are found than neurons in the brain; 
however, the total number of astrocytes is modulated to accommodate the 
number of neurons. In contrast to oligodendrocytes, astrocytes are highly 
reactive and proliferative under certain circumstances (e.g. traumatic injury 
and tissue hypoxia) [47]. 
 
1.2 Neurogenesis and dementia 
NSCs and other types of neural cells derived from them provide the cellular 
basis of neural development. Aberrant neurogenesis may impair the normal 
neural development and lead to neurodegenerative disease. Age-related 
neurodegenerative diseases have become a significant problem all over the 
world, among which dementia is a prevalent type, usually characterized by 
diminishing or functional loss of neural cells. Reports show that about 10% 
elders above 65 years old and 47% above 85 years old exhibit symptoms of 
dementia [48]. Affected cognitive capacity may display as memory loss, 
amnesia, loss of attention, impaired language ability etc. 
Neurogenesis is a complex process that requires multiple levels of regulation 
and coordination, including intrinsic mechanisms (e.g. transcriptional factors 
and signaling pathways), as well as extrinsic factors such as age and diseases. 
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Several essential genes, such as presenilin-1 (PS-1) and tau that are involved 
in the pathological onset of dementia regulate embryonic neural development 
as well [49, 50]. Moreover, some neurogenic areas are affected in dementia 
(e.g. hippocampus and olfactory bulb), of which the physiological functions 
are aligned with the capacity impaired under pathological circumstances of 
dementia. Conversely, pathological alterations may alter neurogenesis to some 
extent. Hence, investigations have been addressed to reveal the correlation 
between neurogenesis and dementia. 
 
1.2.1 Neurogenesis and Alzheimer’s disease (AD) 
Alzheimer’s disease (AD) is one of the most well-known dementia with a 
frequency of 70% among all dementia [51]. AD is histopathologically 
characterized by neuronal and synaptic loss that are resulting from the 
formation of senile plaques and neurofibrillary tangles [52]. The amyloid 
hypothesis indicates that the accumulation of beta-amyloid (A") fragments 
that forms the central core of senile plaques contributes to AD pathology. The 
senile plaques appear when A" clearance does not accommodate its formation 
coordinately, and the extracellular aggregated A" may impair the intracellular 
connection of brain cells [53]. Some specific mutated genes, such as amyloid 
precursor protein (APP), presenilin-1 (PS-1) and presenilin-2 (PS-2), cause 
the aberrant accumulation of A" from APP [54, 55]. In addition to A" 
pathology, tau hypothesis indicates that a microtubule-associated protein tau is 
also crucial to tangle pathology. The hyperphosphorylated tau proteins 
aggregate to form the neurofibrillary tangle, which is thought to be a primary 
marker of AD [56]. Evidence shows that tau is involved in regulating 
proliferation and differentiation of hippocampal neuronal precursors [50], 
implying the potential correlation between neurogenesis and AD. 
In the past decades, mounting evidence demonstrated that neurogenesis was 
compromised in AD. Mice with one or both of mutations in APP and/or PS-1 
displaying similar AD pathological symptoms as human are widely used as 
transgenic mice in AD research [48]. A decrease of adult neurogenesis in the 
dentate gyrus was found in a PS-1 mouse model though environmental 
housing conditions were enriched [57]. Another mice model APP-23 exhibited 
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increasing neurogenesis under environmental enrichment intervention; 
however, basal neurogenesis still declined [58]. Besides, a decrease in SGZ 
neurogenesis was found in an APP model, and surprisingly accompanied with 
an increase in the proliferation of immature neurons; however, the overall 
neurogenesis was downregulated in this model [59]. Moreover, a study 
performed on APP/PS-1 directly suggested the suppressing effect of A" in 
neurogenesis, which showed an attenuated survival and a lower potential in 
generating new neurons of NPCs [60]. Furthermore, increased length of 
dendrite, spine density and functional response were observed in early 
developmental neurons of an APP model, whereas during later maturation 
they were impaired in morphology and functions [61]. On the other hand, less 
evidence can be found associated with neurogenesis in terms of the tangle 
pathology, as fewer models are available at the moment. Nevertheless, tau is 
regulating neuronal development in hippocampus. Decreased differentiation 
and neurite outgrowth resulting from tau deletion according to in vitro 
observation [48]. Human 4R tau knock-in mouse model is used to show an 
overall increase in the cell number and size of the hippocampus [50].  
Conversely, the potential inducing effect of chronic neurodegeneration in 
NSCs proliferation and differentiation is still controversial. An in vitro study 
performed in the striatal- and hippocampal-derived NSCs exhibited an 
enhanced neuronal differentiation due to exogenous A" peptide [62]. Another 
transgenic mice study showed an increase in neurogenesis before and after the 
A" accumulated [63].  
Taken together, studies demonstrated that neurogenesis is most likely to be 
affected in AD, exhibiting as an overall decrease under AD pathological 
conditions.  The discrepancy could be due to the magnitude of AD, age, and 
sub regions investigated. 
 
1.2.2 Neurogenesis and subcortical ischemic vascular dementia 
(SIVD) 
As the second most prevalent type of dementia following with AD, vascular 
dementia (VaD) constitutes 15% of all dementia [64]. This type of dementia 
accounts for 20% of the 25 million dementia cases all over the world, and 
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contributes to the pathological burden of 40% AD patients [65]. Around 20% 
patients who suffered acute ischemic stroke develop dementia after stroke 
attack [66, 67]. Subcortical ischemic vascular dementia (SIVD) is known as a 
small-vessel vascular dementia, resulting from ischemic injury in deep 
cerebral white matter, such as complete infarction (lacunar infarct and 
microinfarcts) and incomplete infarction [68]. The impairment of several brain 
areas (e.g. basal ganglia, internal capsule, thalamus, pons etc.) leads to 
affected cognitive and motor functions, mood changes, loss of self-awareness 
and so on. The ischemic white matter lesions produce several pathological 
features, such as generation of astrocytic gliosis, rarefaction due to loss of 
oligodendrocytes, and loss of myelin and axons [68]. 
As an acute injury, ischemia can strikingly alter the physiological 
microenvironment, such as the concentration of oxygen and ATP, cellular 
ionic homeostasis and neurotransmitter release [69]. The dramatic changes in 
energy metabolisms imply that the compromised blood flow in the brain may 
eventually result in massive loss of neural cells in affected areas. Indeed, 
alteration in oxygen concentrate accompanied with ischemic injury regulates 
NSCs proliferation and differentiation [70-72]. Ischemia leads to an 
upregulation of the proliferation of NSCs in SVZ and SGZ.  Increasing 
number of immature neurons and the induced neuronal migration are observed 
in ischemia [73]. A study found that newborn neurons appear around ischemic 
infarcts, and preferentially localize near the blood vessels [74]. These findings 
suggest the existence of an ischemia-induced compensatory neurogenesis. 
Another comparative study based on VaD patients and age-matched controls 
showed the presence of proliferating NSCs, as well as a dramatic increase in 
the number of NSCs, in ischemia-affected areas and SVZ in dementia patients. 
This effect is likely to be dementia-magnitude dependent as older (occurring 
over 3 months prior to death) infarcts areas showed more significant increase 
in PSA-NCAM and doublecortin (DCX) positive cells than new (occurring 
less than 3 months prior to death) infarcts areas [65]. In addition, several 
growth factors regulating NSCs proliferation and differentiation are affected 
by ischemia and involved in post-ischemia neurogenesis, such as FGF-2 [75] 
and brain-derived neurotrophic factor [76]. 
Taken together, the self-renewal and differentiation of NSCs, as well as the 
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growth of differentiated neural cells are crucial for normal neural development 
and pathological conditions. So far the correlation between neurogenesis and 
dementia has not been clearly illustrated, as the underlying mechanisms 
regulating these biological events have not been clearly understood. 
Elucidating how the proliferation and differentiation of NSCs are altered in 
dementia may unveil the pathology of dementia at the cellular level. The 
regulating network in NSCs and other types of neural cells during normal 
neural development highly likely contribute to the pathogenesis of dementia as 
well. Thus, information from the cellular basis and dementia impaired brain 
tissues may help elucidate the modulating mechanisms in normal and aberrant 
neural development, and hopefully identify extrinsic and intrinsic controlling 
factors to generate more fate-specific and functional neural cells, which could 
be a potential therapeutic approach for traumatic injury and neurodegenerative 
diseases. 
 
1.3 Roles of lipids in neurogenesis and dementia 
Lipids were a class of molecules under the shadow of genes and proteins 
decades ago. In recent years, the crucial roles of lipids in biological events 
have been suggested by studies in their upstream genes and enzymes. More 
than storage compounds in energy metabolism, these naturally occurring 
molecules are major components of plasma membranes, implicated in 
membrane dynamics and trafficking. Moreover, the bioactivity of several lipid 
species makes them second messengers in signaling pathways to regulate cell 
survival, apoptosis, proliferation and migration [77]. 
 
1.3.1 Structure and cellular functions of lipids 
The enormous structural diversity of lipids makes it difficult to categorize 
them in a defined manner. Here I categorized lipids in this study into five 
groups, known as fatty acyls (FA), glycerolipids, glycerophospholipids, 
sphingolipids and sterols (Figure 1-2). 
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Fatty acyl chain characterized by a series of methylene groups is the major 
lipid structural component in more complicated lipids. The structure of fatty 
acyl can vary upon its chain length and number of double bonds.  
Glycerolipids include all glycerol-containing lipids in general, however, I 
categorize glycerophospholipids into a different group in this thesis. 
Diacylglycerol (DAG) and triacylglycerol (TAG) are the most well known 
glycerolipids.  
Glycerophospholipids count for the major composition of lipid bilayer in the 
plasma membrane. The biological nature of phospholipids in this category is 
based on the structure of the polar head group at the sn-3 position of the 
glycerol backbone in eukaryotes and possibly stereospecific due to 
substituents at sn-1 and sn-2 [78]. Thus, distinct subclasses of phospholipids 
are defined by head group, including phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylserine (PS), 
phosphatidylglycerol (PG), and phosphatidylinositol (PI). Individual species in 
each subclass can be distinguished by fatty acyl chain length and double bonds 
in hydrocarbon moieties. Moreover, ester, ether or vinyl linkage can be 
introduced to the glycerol backbone, giving rise to ether/ester phospholipids. 
Sphingolipids are characterized by a common saturated or monounsaturated 
sphingosine backbone. This class of lipid can be subdivided into different 
categories based on head groups. As the precursor of several other 
sphingolipids, ceramide (Cer) is comprised of sphingosine and an amide-
linked fatty acid, usually saturated or monounsaturated. A variety of sugar 
headgroup can also be attached to Cer backbone to generate glycosphingolipid 
(e.g. glucosylceramide (GluCer), galactosylceramide (GalCer) and 
ganglioside).  
The most important sterol in mammalians is cholesterol (ChoL). Oxysterols, 
such as 24S-hydroxycholesterol (24S-OH), 7-hydroxycholesterol (7-OH) and 
7-keto-cholesterol (7-keto), can be derived by introducing hydroxyl group at 
different positions on the ring structure of ChoL. The structural specificities of 
oxysterols are pertaining to distinct biological functions in mammalian. 
The structural diversity of lipids accommodates their diverse cellular functions 
in mammalian cells (Figure 1-2). Glycerophospholipids (e.g. PC), 
sphingolipids (e.g. SM) and sterols (e.g. ChoL) constitute the major portion of 
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plasma membranes. These lipids are distributed heterogeneously in 
membranes interacting with proteins to form tightly packed microdomains, 
which serve as platforms for downstream signaling pathways. Some lipids are 
specifically distributed in certain organelles. For instance, endosomes are 
enriched with lysobisphosphatidic acid (LBPA). Bioactive signaling lipids 
(mediator lipids) can be derived through the metabolism of membrane lipids. 
These soluble molecules are involved in many physiological processes. 
Neutral lipids, such as cholesteryl ester (CE) and glycerolipids, are mostly 
stored in lipid bodies [77]. 
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Figure 1-2. Structure diversity and cellular functions of lipids (adapted from [77]). Fatty 
acyl chains are building blocks of glycerophospholipids and sphingolipids. The head groups 
of glycerophospholipids define the lipids subclass (e.g. phosphatidylcholine). Together with 
sterols, glycerophospholipids and sphingolipids form the major part of plasma membranes 
(blue box). Some lipids are spatially restricted (grey box). Glycerolipids and sterol-esters are 
mainly stored in lipids bodies (green box). Bioactive lipids are involved in various signaling 
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The diversity and complexity of lipids require a powerful approach to 
investigate this huge class of molecules at a systematic level. Though the 
crucial roles of lipids have been implied by genomics or proteomics studies, a 
dearth of direct evidence for downstream metabolites still restrains the 
understanding of lipids in numerous essential biological events. Lipidomics is 
an emerging field investigating lipids from a systematic and comprehensive 
view. By employing mass spectrometry (MS), lipids with complex chemical 
structures can be fragmented into smaller sections for more specific and 
sensitive analysis. Several technical developments, such as electrospray 
ionization (ESI) and atmospheric pressure chemical ionization (APCI), 
overcome the earlier limitation in lipidomics and move the process forward 
[79]. ESI is a soft ionization method with high sensitivity and resolution 
giving multiply charged ions. Most of the polar lipids can be detected by 
coupling ESI with tandem mass spectrometry (ESI-MS/MS), while relatively 
nonpolar lipids is commonly better ionized by APCI, which is generating 
monocharged ions. The resolution of lipids in a complex mixture can be 
improved with the combination of upfront high-performance liquid 
chromatography (HPLC). Thus, LC-MS could cover most polar (e.g. 
glycerophospholipids) and apolar lipids (e.g. DAG and TAG).  
Non-targeted profiling is aiming to reveal unexpected lipids under a given 
condition.  This approach is useful when the entire cellular lipid profile has 
not been completely known [80]. However, the sensitivity and specificity of 
quantification might be compromised to some extend. In comparison to the 
non-targeted approach, targeted profiling could quantify defined lipids of 
interest with enhanced sensitivity and detailed characterization. Quantification 
of selected lipid species can be achieved by triple quadrupole instruments with 
a method called multiple reaction monitoring (MRM), which requires solid 
knowledge in the molecule’s fragmentation pattern. Though MRM list could 
only focus on limited range of lipids, the targeted lipids of interest in brain 
cells and tissues can be selected based on previous literatures and MRM list 
established [81]. Therefore, in order to obtain quantitative lipid profiles with 
higher sensitivity, here MRM was employed to detect major membrane lipids, 
as well as several bioactive and neutral lipids, in various brain cells and tissues. 
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1.3.2 Roles of lipids in NSCs proliferation and differentiation 
 
 
Figure 1-3. Lipids in self-renewal and differentiation of NSCs, and neuronal growth 
(adapted from [21-23]).  Lipid content and metabolism regulate the switch between self-
renewal and differentiation of NSCs, as well as the further development of neurons. Lipids: 
cholesterol (ChoL), fatty acyls (FA), ceramide (Cer), glucosylceramide (GluCer), 
galactosylceramide (GalCer), sphingosine-1-phosphate (S1P), sphingomyelin (SM). !
The NSCs niche is comprised of a diversity of neural cells. The unique feature 
of each type of cell suggests that the metabolic state is likely to be 
dramatically varied between differentiated cells and self-renewing multipotent 
NSCs [82]. Previous transcriptome studies revealed significant changes in 
energy metabolic related genes [83]. A new idea emerged that energy 
metabolism and redox state are critical modulators in NSCs fate decision 
process. It is believed that NSCs that stay in a more oxidized environment 
would preferentially undergo differentiation rather than remain multipotent. 
Cells produce reduced glutathione (GSH) to limit the oxidative damage caused 
by reactive oxygen species (ROS), such as DNA damage and oxidation of 
lipids. The changes of intracellular redox state indicated by GSH levels 
suggest that oxidative stress exists during embryonic stem cells differentiation. 
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A metabolomics study revealed that embryonic stem cells have abundant 
unsaturated metabolites (e.g. fatty acids) whose levels decrease upon 
differentiation [84]. In glial progenitors differentiation, redox state exhibits 
consistent potentiating modulation. The differentiation of oligodendrocytes 
and astrocyte precursors is enhanced by oxidation, while GSH maintains the 
proliferating state of precursor cells [85, 86]. Thus, as a pivotal component in 
energy and redox state, the metabolism especially the unsaturation degree and 
oxidation of lipids might account for the energy and redox regulation in NSCs 
proliferation and differentiation. 
Except for the fundamental structural and energetic roles, lipids are bioactive 
in many signaling pathways that are regulating NSCs proliferation and 
differentiation via receptors in plasma membranes and nuclear, or protein 
kinases. 
Sterols are playing important roles in modulating the Sonic hedgehog (Shh) 
signaling pathway, which is involved in neurogenesis. In vitro, Shh is required 
for NSCs self-renewal from both SVZ and SGZ [87, 88]. The proliferation of 
neurosphere-forming stem cells is regulated by Shh that is coordinating with 
EGF [87] by Shh receptors patched (Ptc) and smoothened (Smo) in neural 
progenitors [89]. Ablation of Smo results in the failure of transformation from 
embryonic NSCs into adult precursors and further impairs adult neurogenesis, 
implying Shh is responsible for expansion and establishment of postnatal 
hippocampal progenitors [90]. The overexpression of Shh in hippocampus 
increased proliferation of progenitors, whereas the inhibition of Shh reduces 
the proliferation of hippocampal progenitors in vivo [88]. Moreover, Shh can 
induce differentiation of progenitors [91]. It has been revealed that lipids are 
involved in modulating Shh signaling. For instance, the maturation and 
activation of Shh require cholesterol (ChoL) modification. ChoL is covalently 
attached to the C-terminal end of Shh, and the modified protein is anchored to 
the plasma membrane [92]. ChoL modification in Shh modulates the 
spreading range of the signaling of the Shh. Lack of ChoL modification 
compromises the effect of Shh as a morphogen during development [93] and 
may lead to a complex brain malformation, holoprosencephaly [94]. 
Reciprocally, ChoL efflux can be reduced by downregulating Ptc. The altered 
intracellular ChoL concentration affects Smo enrichment in the plasma 
  16 
membrane, which is implicated in further effects of Shh signaling [95]. In 
addition to the C-terminal end modified by ChoL, Shh is acylated on its N-
terminal, probably by palmitic acid [96]. This N-terminal fatty-acylation of 
Shh is essential to induce the differentiation of NSCs, and mutation at the 
acylation site severely impairs the ventral forebrain neuron patterning [97]. 
The oxysterols are also involved in modulating the activity of Shh. Studies 
show that Shh can be activated by oxysterol via binding to Smo, and this 
effect is regioselective and stereospecific [98]. Shh regulated proliferation is 
decreased by inhibiting sterol synthesis in cancer cells, and this effect can be 
rescued by introducing ChoL or specific exogenous oxysterols (e.g. 25-OH 
and 24S-OH), which leads to the enhancement of Smo activity [99]. The 
activating effect of oxysterols on Smo also regulates the differentiation of 
pluripotent mesenchymal cells, directing the cells to a fate-committed lineage 
[100]. Hence, the interaction between oxysterols and Shh is most likely to 
regulate the proliferation and differentiation of NSCs. Another receptor that 
has been shown to interact with sterols is sigma receptor in the endoplasmic 
reticulum (ER). Cho in membrane microdomains is associated with sigma 
receptor [101], mediating the galactosylceramide induced oligodendrocyte 
differentiation [102]. 
Sphingolipid is another lipid subclass actively functioning in NSCs 
proliferation and differentiation signaling pathways. The atypical protein 
kinase C (aPKC) is a protein kinase family involved in several essential 
signaling pathways for cell survival and proliferation, such as Akt signaling 
[103]. Ceramide (Cer) can bind to aPKC in vitro at the classical C1 domain 
[104] or the C-terminal of the enzyme [105]. The Cer-aPKC complex 
regulates the enzyme activity in a biphasic manner as the enzyme is activated 
at a low dose of Cer while inactivated at a high dose. The activation effect can 
be inhibited by arachidonic acid [106]. The prostate apoptosis response-4 
(PAR-4) interacts with PKC as an inhibitor of its enzymatic activity in cell 
survival and apoptosis [107]. Studies show that inhibition of Cer synthesis, 
concurrent with the knockdown of prostate apoptosis response-4 (PAR-4) 
reduces the NSCs apoptosis. Conversely, additional exogenous Cer and 
overexpression of PAR-4 enhance apoptosis. Moreover, asymmetric 
distribution of PAR-4 is observed in proliferating NSCs, giving rise to a fate-
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committed daughter cell with upregulated PAR-4 and Cer that lead to 
apoptosis [108]. Thus, it is highly possible that Cer is coordinating with PKC 
and PAR-4, to regulate cell survival and apoptosis. Furthermore, it has been 
proposed that the balance between Cer and its derivatives (e.g. sphingosine-1 
phosphate (S1P)) rather than Cer alone regulates NSCs differentiation. Cer 
modulates GSK-3" activity in a biphasic manner. It promotes the migration of 
neural precursor cells by an aPKC-mediated inactivation of GSK-3" [109], 
whereas the neuronal apoptosis can be induced by inhibiting the antiapoptotic 
kinase Akt, which downregulates the phosphorylation of GSK-3" [110]. The 
biphasic effects might be modulated by sphingosin-1-phosphate (S1P) which 
binds to G-protein coupled receptors (GPCRs) [111], or other intracellular 
partners (i.e. histone deacetylase) [112]. Neural precursor cells without S1P 
receptors are susceptible to Cer-induced apoptosis due to upregulation of 
PAR-4, while those with S1P receptors can be protected by S1P analog [113]. 
Furthermore, supplementation of S1P or its analog in neural precursor cells 
results in an oligodendrocyte lineage restricted fate choice during the 
differentiation [113], in contrast, neuronal differentiation is promoted by Cer 
analog [111]. Therefore, Cer/S1P may reciprocally cooperate during the 
proliferation and differentiation of NSCs with opposite effects. In addition, 
glycosphingolipids have drawn intensive attention on their effects in NSCs 
survival and growth. B-series complexes of gangliosides are involved in Cer-
induced apoptosis by modulating PAR-4 expression level. The abundance of 
gangliosides changes dramatically during early embryonic neural development. 
NSCs differentiation can be regulated by lacto/globo- and ganglio series 
glycosphingolipids via a compensation mechanism, with simpler species cover 
a larger range of differentiation stages [111]. Gangliosides deficiency in mice 
could lead to abnormal neural development, such as diminished brain size and 
neuronal apoptosis [111]. Another galactosylated derivative of Cer is GalCer 
with a galactose residue at the 1-hydroxyl moiety instead of glucose head 
group in GluCer. Its sulfated analogue, SL is a negative regulator in 
oligodendrocyte differentiation [114]. 
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1.3.3 Roles of lipids in neuronal growth and astrocytes 
1.3.3.1 Roles of lipids during neuronal growth 
The growth of neurons consists of processes that require a large amount of 
membrane materials, including axonal and dendritic generation and expansion, 
as well as the formation of the synapse. Hence during the phase of enormous 
membrane surface build-up, the demand of lipids is indispensable. The 
neuronal growth starts with the neurite generation once the neuron reaches its 
targeted region. Membrane materials are delivered between cell body and the 
growth cone by intracellular vesicles that mediate anterograde and retrograde 
transportation [115, 116].  Mounting evidence shows that lipids are required 
for neuronal growth and are primarily synthesized in the cell body. For 
example, ChoL synthesis is detected in the cell body and transferred along 
axon. Inhibition of ChoL synthase impairs the axonal growth [117]. However, 
no axonal ChoL biosynthesis has been observed so far [118, 119]. On the 
other hand, biosynthesis of phospholipids and sphingolipids are found in both 
cell body and distal axon, including PC, PE, PI, PS and SM [120, 121], and 
the local synthesis is required for axonal elongation [122]. Inhibition of SM 
synthesis as well as GluCer [123] disrupts axonal growth in hippocampal 
neurons [124]. Supplementary fatty acid or the overexpression of its synthase 
enhances the neurite growth [125]. PC synthesis is closely correlated with the 
neurite growth [126], since inhibition of PC synthesis impairs the elongation 
of axon [127]. 
On the other hand, the distribution of proteins and lipids occurs concurrently 
with the membrane constitution. Neurons are highly polarized cells with 
specific axonal and dendritic structure. Lipids and proteins are distributed 
heterogeneously from the cell body to the axon. Lipid raft, a ChoL and 
sphingolipids enriched microdomain, may play important roles in cell 
polarization. Extrinsic information regulating axonal polarization and 
migration can be translated into local signals and delivered into cells by cell 
adhesion molecules (CAMs) or receptors that are expressed by growth cone 
[128]. These cell-surface proteins distribute and act differentially in the raft or 
the non-raft membrane domains. For example, lipid raft associated neural cell 
adhesion molecule (NCAM) activates tyrosine-kinase signaling pathway or 
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FGF to induce neurite outgrowth, whereas disruption in NCAM-raft 
interaction decreases the activation of NCAM in both signaling and further 
inhibited neurite outgrowth [129]. Another example is the regulation in axon 
guidance by netrin-1 and its receptor. The association between lipid raft and 
the receptor of netrin-1 is required for axon outgrowth, which is mediated by 
netrin-1 induced ERK activation [130]. In this manner, the lipid raft can act as 
a platform for many cellular signaling pathways involved in axon guidance 
and growth. 
 
1.3.3.2 ChoL homeostasis in neurons and astrocytes 
Extensive studies have addressed the importance of the communication 
between neurons and astrocytes. The molecules secreted by astrocytes have 
been shown to modulate the growth of neurons. In addition to growth factors, 
lipids are also transported between these two types of neural cells. Both 
neurons and astrocytes require a high amount of cholesterol (ChoL). However, 
the ChoL synthesis in neurons and astrocytes are differentially regulated. 
Astrocytes produce ChoL at a higher rate compared to neurons [131]. 
Newborn neurons have to synthesize ChoL locally for survival [132]; in 
contrast, ChoL can be obtained from other cells in adult neurons [133]. 
Astrocytes are believed to be the primary source of ChoL importation for 
neurons. ChoL together with several precursors (i.e. desmosterol) can be 
secreted by astrocytes via glia-generated APOE-containing lipoproteins [134], 
which is comprised of ChoL, phospholipids, cholesterol esters (CE) and 
triglycerides (TAG). This secretion is mediated by ATP-binding cassette 
(ABC) transporters that are found in endosomal vesicles [135]. Besides, liver 
X receptors (LXRs) control the ChoL efflux by modulating the expression 
levels of related proteins such as APOE and ABC transporter [136]. Secreted 
particles containing ChoL are taken up by neurons via low density lipoprotein 
receptor (LDLR) and the low-density lipoprotein receptor-related protein 1 
(LRP1) [137], and delivered to different subcellular organelles by endosomal 
vesicles-mediated trafficking [138]. Elevated ChoL is found in late endosome 
or lysosome if the endocytosis is impaired [139]. 
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1.3.4 Roles of lipids in dementia 
The close correlation between neurogenesis and dementia prompts us to 
speculate that the regulating mechanisms underlying neurogenesis could also 
contribute to the pathology of dementia.  The brain is a lipid-rich organ in the 
human body as more than half of its dry weight is constituted by lipids. As 
both structural and bioactive functional components, the multiple levels of 
modulation from lipids make them as potential candidates that contribute in 
the pathological mechanisms of dementia. Indeed, an increasing body of 
evidence shows that lipid composition and metabolism are of great importance 
in dementia.  
Genetics studies suggested the involvement of lipid metabolism in AD [140]. 
Indeed, it has been shown that most classes of lipids are implicated in AD 
pathogenesis, such as the production and aggregation of A". For instance, the 
balance between cholesterol (ChoL) and cholesterol esters is regulating the 
generation of A". Excess cholesterol can be converted to cholesterol ester (CE) 
by sterol O-acyltransferase 1 (ACAT1). Elevated CE also leads to the 
upregulation of A" [141, 142], whereas inhibition of ACAT1 results in the 
reduction of both CE and A" [143, 144]. Moreover, ChoL can modulate the 
activity of secretases that are responsible for the cleavage of amyloid 
precursor protein (APP) via lipid raft. Attenuated membrane ChoL leads to 
decreased production of A" due to the suppressed activity of "-secretase and 
#-secretase that is located in the ChoL-rich lipid raft [145, 146], while lower 
ChoL abundance stimulates !-secretase that prevents the production of A" by 
modulating the fluidity of membrane domain with higher long-chain 
polyunsaturated fatty acyl containing phospholipids [147]. Sphingolipids are 
also implicated in amyloidogenesis. Ceramide (Cer) levels are increased in 
AD, which might mediate oxidative stress-induced neuronal death [148]. By 
inhibiting the activity of #-secretase, sphingomyelin (SM) accumulation can 
directly downregulate A" [149]; however, suppressing the entire biosynthetic 
pathway of sphingolipids increase the production of A"42 but A"40 [150]. 
The upregulation of another class of lipid-raft enriched sphingolipids, 
gangliosides, are aligned with the increase of A" fibrils [151], and regulate the 
calcium homeostasis, which modulate the phosphorylation of tau and APP 
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[152]. Phospholipids, such as phosphoinositides (e.g. phosphoinositol-4, 5-
bisphosphate) correlate with the level of A" [153]. Besides, phospholipase D1, 
which hydrolyses phosphatidylcholine into phosphatidic acid, negatively 
regulates the processing of APP [154]. In terms of the aggregation of A", 
gangliosides (e.g. GM1) can bind A" and involved in seeding A" aggregation 
in neurons [155]. On the other hand, ChoL and phosphoinositides are involved 
in the phosphorylation of tau protein [156].  
Taken together, alterations in certain lipid species are likely to be responsible 
for the pathogenesis of dementia, whereas the changes of the comprehensive 
lipid composition and metabolism, especially in VaD, have not been clearly 
elucidated yet. 
 
1.4 Objectives of the study 
As described above, neurogenesis and gliogenesis form the cellular basis of 
neural development. The impairment of these processes could strongly 
contribute to the pathology of neurodegenerative diseases, such as dementia; 
on the other hand, pathological conditions may reciprocally alter neurogenesis. 
Information in the fields of genomics and proteomics have implied the 
important roles of lipids in NSCs, differentiated neural cells, as well as in 
dementia. Accumulative evidence additionally shows the involvement of 
lipids in these biological events, while the investigations are usually restricted 
within certain subclass or particular individual species.  The lack of a 
comprehensive and detailed lipidomics study in NSCs and differentiated 
neural cells at a system level retards the progress in revealing the complex 
modulating network. The collecting and understanding of corresponding 
information in lipid composition and metabolism from both in vitro neural cell 
culture systems and brain extracts of dementia patients are indispensable for 
generating further hypothesis and revealing the roles of lipids during neural 
development. These fundamental lipidomics data could suggest promising 
directions for future investigations in neural cells and neurodegenerative 
diseases respectively, and the comparison between cellular basis and clinical 
samples would unmask the correlation between neurogenesis/gliogenesis and 
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the pathogenesis of dementia at the cellular level. Therefore, the main 
objectives of this study are (Figure 1-4): 
1) Revealing the lipid composition and establishing the differentially 
regulated lipid network in NSCs compared with the fate-committed 
progenitors and differentiated cells by analyzing the comprehensive 
lipid profiles during the NSC-enrichment in neurospheres for the first 
time. 
2) Establishing the first comparison of lipid profiles between neurons and 
astrocytes to illustrate the difference of their biological properties, and 
understanding the roles of lipids during neuronal growth by detecting 
lipid profiles in neurons at different developmental stages. 
3) Obtaining comprehensive lipid profiles in dementia patients and 
age/gender matched controls to identify novel molecular therapeutic 
targets for dementia and confer new insights pertaining to lipid 
pathology in contributing to dementia. 
4) Relating the lipid profiles based on in vitro cell culture systems with 
that obtained from brain tissues of dementia patients and trying to 
elucidate pathology of dementia at the cellular level.
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Figure 1-4. Project outline of lipidomics studies in neural development. Lipidomics studies were performed 1) during the proliferation of NSCs and progenitors 
(neurosphere assay); 2) in differentiated neural cells and during neuronal growth (neuronal and glial culture systems); and 3) in brain tissues from SIVD and MIX patients
Neurological diseases Differentiated cells Progenitors ! 
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2. Lipidomics analysis of NSC-enriched neurospheres 
2.1 Introduction 
Neural stem cells (NSCs) are characterized as multipotent cells that can self-
renew and differentiate into all major types of neural cells [1]. The ability of 
self-renewal is an integration of proliferation control to maintain NSCs in an 
undifferentiated state. Meanwhile, the asymmetric division of NSCs generates 
differentiated cells to accommodate the function of the brain. NSCs serve not 
only as a source of cell renewal and repair in the homeostasis of the brain, but 
also as a promising therapy for neurodegenerative diseases and traumatic 
injury. Therapeutic NSCs transplantation has been done in animal models 
[157-159]. However, some limitations such as tumor formation compromise 
the clinical application of NSCs [160]. Generating more fate-specific and 
functional neurons becomes the biggest challenge for NSCs therapy. 
Therefore, characterization of cells in vitro is very important to fully 
understand NSCs properties and find out controlling factors in NSCs 
proliferation and differentiation. 
A wealth of studies revealed the regulating mechanisms in NSCs. The 
involvement of a large body of molecules in the proliferation and 
differentiation of NSCs indicated the complexity of the controlling network in 
these biological events. Thus, numerous genomics and proteomics studies in 
NSCs have been done to illustrate the essential signaling pathways from a 
systematic perspective [161-168]. In addition, lipids known as major 
components of plasma membrane and signaling molecules also exhibit their 
bioactivity in regulating the self-renewal and differentiation of NSCs. Studies 
are beginning to unmask the importance of these downstream metabolites in 
neural development. However, a comprehensive lipid profile has not been 
done in NSCs yet. The detailed lipidomics study could reveal the lipid 
composition and metabolism of NSCs, and would be crucial to identify 
potential lipid factors controlling the proliferation and differentiation. 
In this chapter, we employed the neurosphere assay to perform a 
comprehensive lipid analysis in NSCs for the first time. Neurospheres assay 
was first described in 1992 [169]. It has been widely used as an in vitro model 
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system to investigate the essential attributes of NSCs, such as proliferation and 
differentiation. This free-floating sphere can be generated from different 
regions of mammalian brains with a 3 dimensional structure imitating the in 
vivo environmental niche of NSCs [170]. Neurospheres consist of bona fide 
NSCs, fate-committed progenitors and differentiated cells. The cellular 
composition of each neurosphere can be contolled by different culture 
conditions, such as cell culture medium, culturing period, cell density and 
passaging frequency [171].  Here I optimized the culture condition of 
neurospheres to establish an assay with increasing NSCs accompanied by 
reducing progenitors and differentiated cells. Lipid profiles of neurospheres 
during the enrichment of NSCs were analyzed. The comprehensive lipidomics 
data combined with previous genomics and proteomics data illustrates that the 
lipid metabolism is differentially regulated in NSCs compared with other 
progenitors and differentiated cells. This result suggests the critical roles of 
lipids in NSCs proliferation and differentiation. Based on the lipid profiles, the 
effects of several lipid candidates have been further verified by performing 
lipid-treatment in proliferation and differentiation assay. The comprehensive 
lipid profile and the effect of lipid-treatment in neurospheres unveil the 
importance of certain lipid classes and individual species in regulating NSCs 
self-renewal and differentiation. 
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2.2 Materials and Methods 
2.2.1 Animal handling and collection of brain tissue 
Animals were acquired and cared for in accordance with guidelines published 
in the NIH Guide for the Care and Use of Laboratory Animals. All procedures 
involving animals were approved by the Animal Care and Use Committee of 
the National University of Singapore under Protocol 001/09. 
The pregnant female (C57BL/6J) was euthanized, and embryonic day 14 
(E14) fetuses were removed. Fetuses were killed by rapid decapitation, 
followed by immediate removal of the brain. Primary cultures were 
established from the cortical tissue of the fetus. 
 
2.2.2 Neurosphere culture 
Dissociated embryonic tissue was digested with trypsin-EDTA (Invitrogen), 
and was grown in DMEM-F-12 (1:1) culture medium (Invitrogen) with 
antibiotics and B-27-supplement (Invitrogen, 1:50) in the presence of 20 
ng/mL EGF (i-DNA) and FGF-2 (Miltenyi Biotec). Cell density was 2!105 
cells/ml. Neurospheres were physically dissociated and transferred into fresh 
medium every 3 days. 
 
2.2.3 Immunocytochemistry 
Neurospheres were dissociated into single cells and attached to cover slips, 
followed with washing by PBS for 10 min (!3 times). 4% paraformaldehyde 
was used to fix the cells for 20 min in room temperature, and cells were 
treated with 0.1% Triton-X-100 (in PBS) for 20 min followed by 10 minutes 
washing with PBS. Cells were incubated with anti-Sox2 (Millipore, AB5603) 
and anti-Neuronal Class III "-Tubulin (TUJ1) (Covance, MMS-435P) in 
blocking solution (5% FBS in PBS) at 4°C overnight, and washed by PBS for 
10 min (!3 times). Secondary alexfluor555/488 antibody was diluted in 
blocking solution and incubated with cells for 1h at room temperature. Cells 
were washed by PBS for 10 min (!3 times). Coverslips were mounted with 
appropriate mounting medium and dry for at least 2 hours. Cells were 
visualized via fluorescence microscopy using an Olympus DP70. 
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2.2.4 Lipid treatment in NSC-enriched neurospheres 
After 10 times of passages of the neurospheres, lipid dissolved in dimethyl 
sulfoxide (DMSO) was added into NSC-enriched neurosphere culture 
medium. Cells were incubated with lipids for 3 days in 37°C. 
 
2.2.5 Proliferation assay 
Neurospheres treated with oxysterols for 3 days were spun down and 
dissociated physically into single cells followed by re-suspending in fresh cell 
culture medium with oxysterols. 5-Bromo-2’-deoxy-uridine (BrdU) labeling 
assay was employed (5-Bromo-2’-deoxy-uridine labeling and detection Kit I, 
Roche Applied Science, 11296736). Briefly, BrdU labeling solution was 
added into cell culture medium at a concentration of 1:1, 000 (v/v) (0.5mL/106 
cells), and cells were incubated for 36h at 37°C. After incubated with BrdU, 
cells were washed by washing buffer for twice (5min, !300g). Cells were 
resuspended in PBS and seeded onto a clean poly-L-lysine coated cover slip. 4% 
paraformaldehyde was used to fix the cells for 20 minutes at room temperature. 
Cells were washed by washing buffer for 10 min (!3 times), and covered by a 
sufficient amount of anti-BrdU antibody (1:10, diluted in incubation buffer) at 
4°C overnight. Cover slips were washed by washing buffer for 10 min (!3 
times), and incubated with Anti-mouse-Ig-fluorescecin working solution (1:10 
in incubation buffer) for 30 min at 37°C, followed by three washes. Cover 
slips were covered with appropriated mounting medium, and observed via 
fluorescence microscopy using an Olympus DP70. 
 
2.2.6 Differentiation of neurospheres 
Lipid-treated neurospheres from E14 cortical tissue were cultured and 
differentiated by seeding mechanically dissociated NSCs (single cell 
suspension) onto poly-L-lysine (Sigma, P2636) and laminin (Sigma, L2020) 
coated glass coverslips. Gliogenesis was induced by growth factor free 
DMEM-F12 (1:1) medium containing 5% FBS and B-27 supplements. 
Neurogenesis was induced by neurobasal medium (Invitrogen) plus B-27 
supplements. Cells were incubated in 37°C for 4-5 days. Neuron (anti-TUJ1, 
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1:500) and astrocyte (anti-GFAP, 1:500) (Dako, Z0334) markers were used to 
stain differentiated cells, and percentage of each type of cell was counted via 
fluorescence microscopy using an Olympus DP70. 
 
2.2.7 Lipid extraction 
A modified protocol of Bligh & Dyer [172] was used to extract lipids from 
cells. Briefly, 900µL of ice cold chloroform-methanol (Fisher), (1:2, volume-
to-volume (v/v) was added to 2!106 cells. After vortexing for 1 minute and 15 
minutes incubation on ice, 300µL of chloroform was added to the mixture, 
followed by mildly vortexing and adding 300µL distilled water. The mixture 
was vortexed for 2 minutes and centrifuged at 14, 000 rpm for 2 minutes at 
4°C.  The lipids were isolated from the lower organic phase. The sample was 
vacuum dried (Thermo Savant SPD SpeedVac with UVS400A Universal 
Vacuum System) and stored at -80°C. 
 
2.2.8 Lipid standards and lipid analysis 
Samples were resuspended in chloroform:methanol (1:1, v/v) prior to lipid 
analysis. Polar lipids were analyzed using an Agilent 1200 high performance 
liquid chromatography (HPLC) system coupled with an Applied Biosystem 
Triple Quadrupole/Ion Trap mass spectrometer (3200 Qtrap) as described 
previously [173]. Multiple reaction monitoring list was adapted from a 
reported study of brain lipidome [81], and targeted lipids were listed in 
Supplementary Table S1. Individual lipid species were quantified using spiked 
internal standards including PC, 14:0/14:0; PE, 14:0/14:0; PS, 14:0/14:0; PG, 
14:0/14:0; C12-SM, C17-Cer, C12-SL as well as C8-GluCer, which were all 
obtained from Avanti Polar Lipids (Alabaster, AL, USA). Dioctanoyl 
phosphatidylinositol (PI, 16:0-PI) was used for lysophosphatidylinositol 
quantitation and obtained from Echelon Biosciences, Inc. (Salt Lake City, UT, 
USA). LBPA was normalized to PG internal standard [81, 173].  
Sterols were analyzed using an Agilent HPLC 1100 system (Agilent) coupled 
with an Applied Biosystems 3200 Qtrap mass spectrometer (Applied 
Biosystems, Foster City, CA) as described previously [174]. Free cholesterol 
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was analyzed with cholesterol-d6 (CDN isotopes) as internal standards. 
Oxysterol standards 7!-hydroxycholesterol-d7, 7-keto-cholesterol-d7, 24S-
hydroxycholesterol-d7 were purchased from Sigma–Aldrich (St. Louis, MO). 
Cholesteryl ester was normalized to cholesterol internal standard. Chloroform: 
methanol 1:1(v/v) was used as blank, and signal intensities at least 3 times 
higher than blank were taken into account for quantification. 
 
2.2.9 Lipidomics data processing 
MRM data were extracted by Analyst Software (Applied Biosystems, Foster 
City, CA, USA). The amounts of lipid classes and individual species were 
normalized by the spiked standard concentration, and then normalized to total 
lipid composition. Molar fractions were used for further analysis. One-way 
analysis of variance (ANOVA) with post-hoc Tukey’s test was performed to 
compare the changes in lipid profiles between different time points (i.e. T1-
T4). The correction of multiple comparisons was done by controlling the false 
discovery rate using the q value (R 3.0.1). ANOVA with post-hoc Tukey’s test 
and correction was done with the help from Xinrui Duan. Data was clustered 
by hierarchical clustering using Pearson correlation distances (centered) with 
average-linkage (Cluster 3.0), and viewed by Java Tree View. 
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2.3 Results 
2.3.1 NSC-enrichment and time point re-arrangement in 
neurosphere assay 
 
Figure 2-1. NSC-enrichment in neurospheres. (A) Day 3 Neurospheres. Scale bar: 100µm. 
(B) Flow chart showing the enrichment of NSCs in neurospheres. Neurospheres were 
dissociated every 3 days and transferred into fresh medium to enrich the bona fide stem cells. 
Immunostaining results indicated that the frequencies of NSCs and neuronal progenitor cells 
(NPCs)/neurons were altered in neurospheres: (C) percentage of Sox-2 positive cells (NSCs) 
was increased (n=6); (D) percentage of TUJ1 positive cells (NPCs and neurons) was 
decreased (n=6). Time points were simplified into four new stages (T1, T2, T3 and T4) 
according to cellular composition change. Alterations in frequencies of (E) NSCs and (F) 
NPCs and neurons were re-calculated based on time point re-arrangement. Error bars 
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The neurosphere assay was employed for lipid profile analysis. Cells isolated 
from cortical tissue of embryonic mice brain was cultured in NSC-preferred 
cell culture medium so as to promote the self-renewal of bona fide stem cells. 
In the presence of EGF and FGF, NSCs were maintained in proliferating 
status. The frequency of cell passage could affect the size and growth rate of 
neurospheres [175], and further alter the cellular composition of neurospheres. 
A short passage period (3 days) was used in this study to enrich NSCs in 
neurospheres over other progenitors and differentiated cells. 
Single NSCs underwent symmetric or asymmetric cell division to generate 
new NSCs or progenitor cells, while some progenitor cells and differentiated 
cells stopped proliferating and might go through cell death. Live cells 
clustered together and formed spherical structures (Figure 2-1. A). Under the 
NSCs preferred growth condition, the frequency of NSCs in neurospheres 
indicated by conventional NSC marker Sox-2 (Figure 2-1. B) was dramatically 
upregulated by the culture strategy employed here, while the percentage of 
NPCs and neurons revealed by neuronal marker TUJ1 was decreased (Figure 
2-1. C), especially at very early time points. Thus, neurospheres turned into 
NSC-enriched at late stages of culture. The enrichment of NSCs in 
neurospheres provided a useful system to investigate the alteration of lipid 
profile during this process and illustrate the role of lipids in NSCs 
proliferation. Notably, the frequency of NSCs did not change significantly 
within a certain time range, such as P6-P8 (Figure 2-1. B). In order to interpret 
the lipid data more clearly, several sequential time points were combined and 
treated as one stage. Original time points (i.e. P1 to P10) were categorized into 
four groups (i.e. T1: P1-P2; T2: P3-P5; T3: P6-P8; T4: P9-P10). The 
simplified time array still maintains the original alteration trend of cellular 
composition in neurospheres. 
 
2.3.2 Lipid alterations during the NSC-enrichment in neurosphere 
Based on the NSC-enriching property of neurospheres and the newly arranged 
time array, the aligned lipid profile alteration was analyzed to show the 
differentially regulated lipid metabolism in NSCs. A total of 151 distinct lipid 
species from 12 lipid subclasses including neutral lipids such as cholesteryl 
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ester (CE), cholesterol (ChoL), 24S-hydroxycholesterol (24S-OH), 7-keto-
cholesterol (7-keto), and 7-hydroxycholesterol (7-OH); sphingolipids 
including ceramides (Cer), glucosylceramides (GluCer), sphingomyelins (SM) 
and sulfatide (SL); as well as phospholipid subclasses of phosphatidylcholines 
(PC), phosphatidylethanolamines (PE), phosphatidylglycerols (PG), 
phosphatidylinositols (PI), phosphatidylserines (PS) and lysobisphophatidic 
acids (LBPA) were analysed. 
At the subclass level, the significant alteration of several lipid classes showed 
a dominant mono-direction change during the whole time frame, including 
PC, Cer, GluCer, SL, ChoL and its derivatives (i.e. 24S-OH, 7-OH, 7-keto, 
CE). However, some lipids were dramatically changed within a shorter time 
range, such as LBPA, showing a drastic early increase from T1 to T2 (Figure 
2-2). Detailed lipid alterations are showed by molecular profiles at individual 
species level. 
Figure 2-2. Changes of lipids at the subclass level during the NSC-enrichment of 
neurospheres (n=9). Lipid abundance of each subclass was normalized to total lipid 
composition and represented as fold change compared to the average value of corresponding 
lipid class within.the whole time range. Error bars represents mean ± S.E.M. Statistical 
significance was determined using one-way ANOVA with post-hoc Tukey test, and the 
correction of multiple comparisons was done by controlling the false discovery rate using the 
q value. *p<0.05, *p<0.01, ***p<0.001. 
 
2.3.2.1 Changes in phospholipids during the NSC-enrichment in neurospheres 
In contrast to the overall increase of PC class, ether PC (ePC) was dominantly 
downregulated, while diacyl-PC, especially the highly unsaturated species, 
was elevated from T1 to T4 in line with the alteration of total PC (Figure 2-3. 
A). The upregulation of the unsaturated diacyl-PC implied that the lipid 
content of NSCs, especially the plasma membrane that contains most PC in 
cells, might be different from other progenitors or differentiated cells. In 
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were also elevated during the enrichment of NSCs (Figure 2-3. B), especially 
PI with a higher degree of unsaturation (!4). Similar as what was observed in 
total LBPA (p<0.05), the relative abundance of all individual LBPA species 
consistently showed an early increase between T1 and T2, whereas the 
individual LBPA amounts did not change strikingly afterwards (Figure 2-3. C). 
The cellular composition change of neurospheres revealed an early reduction 
of NPCs/neurons from T1 to T2 (Figure 2-1. E) paralleled with the alteration 
trend of LBPA. This comparable alteration implied that the decreasing LBPA 
might be correlated with the reduction of NPCs/neurons. 
 
Figure 2-3. Changes in phospholipids during the NSC-enrichment of neurospheres 
(n=9). (A) Heatmap illustrates the fold change of individual lipid species in neurospheres 
from the subclasses of ether PC (ePC) and diacyl-PC. Fold changes were plotted on a z-score 
color scale with blue representing low fold change and red representing high fold change. 
Barplots indicate fold change of individual species of (B) PI and (C) LBPA. Lipid abundance 
of individual species was normalized to total lipid composition and was plotted as the fold 
change over the average value of corresponding species within the whole time range. Error 
bars indicate mean ± S.E.M. Statistical significance between T1 and T4 was determined using 
one-way ANOVA with post-hoc Tukey test, and the correction of multiple comparisons was 
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2.3.2.2 Alterations in sphingolipids during the NSC-enrichment in 
neurospheres 
Significant reductions in the subclasses of Cer, GluCer, and SL (p<0.001) 
were observed in NSC-enriched neurospheres. Moreover, molecular profiles 
of sphingolipidome showed that individual lipid species from these three 
subclasses were consistently decreased from T1 to T4 (Figure 2-4). The 
parallel reduction in Cer, GluCer, and SL suggested that the diminished 
volume GluCer and SL might have been resulted from the attenuated 
biosynthesis of upstream Cer. 
 
Figure 2-4. Changes in sphingolipids during the NSC-enrichment in neurospheres (n=9). 
Barplots indicate fold changes of individual species of (A) Cer, (B) GluCer and (C) SL. Lipid 
abundance of individual species was normalized to total lipid composition and was plotted as 
the fold change over the average value of corresponding species within the whole time range. 
Error bars indicate mean ± S.E.M. Statistical significance between T1 and T4 was determined 
using one-way ANOVA with post-hoc Tukey test, and the correction of multiple comparisons 
was done by controlling the false discovery rate using the q value. *p<0.05, *p<0.01, 
***p<0.001. !
2.3.2.3 Reduced sterols during the NSC-enrichment in neurospheres 
An appreciable decrease of ChoL, accompanied by a concomitant decrease in 
CE and all oxysterols was found in NSC-enriched neurospheres (p<0.001) 
(Figure 2-2). ChoL is a major sterol component in the brain [176]. As ChoL 
derivatives, oxysterols can be produced by introducing different types and 
numbers of oxygenated function group into separate positions of ChoL. All of 
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24S-OH accounts for most if not all the degradation of ChoL in the brain 
[177]. Therefore, the remarkable reduction of oxysterols can be explained by 
the decrease of upstream ChoL. Meanwhile, the concentration of oxysterols 
also regulates the metabolism of ChoL by feedback pathways [178]. Aligned 
reduction of CE was also observed during the enrichment of NSCs. This 
esterified ChoL is linked with a long fatty acyl chain via its hydroxyl group 
catalyzed by different ChoL acyltransferase [179], incorporated into 
lipoprotein for intracellular transportation [180]. The metabolisms of CE, 
oxysterols and ChoL are closely correlated, and the balance between them is 
the key factor regulating sterol homeostasis in NSCs. 
 
2.3.2.4 Hierarchical clustering unveiled interactions among lipid metabolisms 
during the NSC-enrichment in neurospheres 
Lipid profile analysis in NSC-enriched neurospheres provides us a general 
idea about the lipid composition in NSCs. In order to reveal the interaction 
between different lipid species, we next performed hierarchical clustering to 
show the coregulations of lipids. 
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Figure 2-5 (A). Hierarchical clustering of lipid alterations during the NSC-enrichment of 
neurospheres (n=9). 
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Figure 2-5 (B). Eight clusters were highlighted to demonstrate different types of lipid 
alterations during the NSC-enrichment of neurospheres (n=9). The clustering is based on 
the similarity between different lipid species. The fold change of individual species at each 
time point over mean value across the whole time frame was plotted on a z-score color scale 
with blue representing low fold change and red representing high fold change. Grey line 
demonstrates the value of each species with the black line illustrating the mean value of all 
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Hierarchical clustering based on the similarity of lipid alteration clearly 
revealed different changing patterns during the NSC-enrichment in 
neurospheres. Generally, lipid species in the same subclass tended to cluster 
together. For instance, all detected PI species showed a similar trend in Cluster 
2, implying that the metabolism of these PI species is highly correlated with 
each other. Another example was Cluster 8, which contained all detected 
LBPA species. The most striking alteration in this cluster happened between 
T1 and T2 when its relative abundance was upregulated. A few unsaturated 
diacyl-PC species came in Cluster 1, together with several unsaturated PE 
species. Interestingly, the number of double bonds in these phospholipids 
species was dominantly ranged from four to seven, and fatty acyl chain length 
varied within C36-C40, implying that the clustering of this group was 
unsaturation degree and chain length dependent. Another three clusters 
(Cluster 3-5) were dominated by sphingolipids (i.e. Cer, GluCer and SL). 
Furthermore, all sterols were clustered with those sphingolipids, suggesting 
that these two lipid classes interact with each other closely, and the rest of the 
ePC might also participate in the network of lipid metabolism. Cluster 6 and 7 
were composed by some ePC and ePE species with medium chain length 
(C34-C38), showing a downregulation from T1 to T4. The metabolism of 
ether lipids was differentially regulated from other diacyl phospholipids. 
Hierarchical clustering result summarized major findings of lipid alteration 
during the enrichment of NSCs. Furthermore, the clustering implied the 
interactions and correlations between different lipid species, which provided 
us with more clues about the lipid metabolism network in NSCs. 
 
2.3.3 Effects of oxysterol treatment on NSC-enriched neurospheres 
proliferation and differentiation 
Based on the lipid profile during the NSC-enrichment of neurospheres, a few 
lipid species were considered as potential regulating factors in NSCs 
proliferation and differentiation. As shown above, the sterol metabolic 
pathway was dominantly downregulated from ChoL to all oxysterols (Figure 
2-3). Besides, oxysterols with relatively smaller molecular weight compared to 
other lipid species that contain fatty acyl chain are more easily to be 
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incorporated into cells in vitro by extrinsic supplementation. Hence, we next 
introduced 24S-OH and 7-keto into NSC-enriched neurospheres, and utilized 
proliferation (BrdU labeling) and differentiation assays to test the potential 
effects of these oxysterols in NSCs proliferation and differentiation. 
 
Figure 2-6. Concentration gradient test of oxysterol-treatment in the NSC-enriched 
neurospheres. Scale bar: 100µm. !
DMSO was used as a vehicle to transport oxysterols (24S-OH and 7-keto) into 
cells, and it did not affect the growth of neurospheres based on morphological 
characters (Figure 2-6). Gradient test showed that when the concentration of 
oxysterol treatment reached up to 500ng/mL, some neurospheres began to 
dissociate, and cell debris appeared. This cell death phenomenon became 
severe as most of the neurospheres degraded into debris when the 
concentration of oxysterol went up to 10µg/mL. However, when the 
neurosphere was fed with oxysterols of not more than 300ng/mL, their 
morphological attributes observed under microscope did not change obviously 
and cells could grow in a healthy state. Therefore, 300ng/mL was used as a 
subtoxic concentration for oxysterol treatment in the proliferation assay and 
differentiation assay (Figure 2-7). 
 
500ng/mL 800ng/mL 1µg/mL 10µg/mL   
500ng/mL 800ng/mL 1µg/mL 10µg/mL  
Control DMSO 100ng/mL 300ng/mL 
Control DMSO 100ng/mL 300ng/mL 
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Figure 2-7. Flow chart of oxysterol-treatment in NSC-enriched neurospheres. Oxysterols 
were introduced into neurosphere culture by DMSO. After 3-day incubation, oxysterols were 
removed from the medium. On one hand, neurospheres were dissociated and divided into two 
groups, one of which was labeled with BrdU. Immunostaining with the anti-BrdU or anti-Sox-
2 antibodies showed the frequencies of proliferating cells and bona fide NSCs. On the other 
hand, differentiation was induced in neurobasal medium plus B27 (neurogenesis) or DMEM-
F12 medium plus FBS (gliogenesis). Anti-TUJ1 and anti-GFAP antibodies were used to 
indicate the frequencies of neurons and astrocytes. !
2.3.3.1 Alterations in lipid composition of NSC-enriched neurospheres 
resulting from 24S-OH or 7-keto treatment 
The conversion between ChoL and 24S-OH is the primary pathway 
responsible for the ChoL homeostasis in the brain, as 24S-OH can be 
transported cross the blood-brain-barrier with a hydroxyl group that makes it 
more polar than its precursor [181]. Lipid profile analysis demonstrated that 
24S-OH was successfully incorporated into the NSC-enriched neurospheres, 
as the amount of 24S-OH was upregulated dramatically after 3-day treatment 
(Figure 2-8. A). It was not surprising that the load of ChoL was reduced by 
24S-OH treatment (Figure 2-8. B), since 24S-OH is known as a potential 
suppressor for ChoL biosynthesis. However, the amount of other lipid species 
was also altered by 24S-OH treatment, such as the diacyl-PC subclass (Figure 
2-8. C). Therefore, it should be noticed that the effect observed in 24S-OH 
treated neurospheres was not only caused by 24S-OH, but also probably due to 
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Figure 2-8. Significant lipid alterations in NSC-enriched neurospheres treated with 24S-
OH (n=3). Barplots indicate the molar fractions of (A) 24-OH (B) ChoL and (C) Diacyl-PC in 
24S-OH treated and vehicle (DMSO) treated neurospheres with error bars representing mean  
± S.E.M. Statistical significant difference was determined by Student t-test, *p<0.05. The 
correction of multiple comparisons was done by controlling the false discovery rate using the 
q value.  
 
Figure 2-9. Significant alteration of 7-keto in NSC-enriched neurospheres treated with 7-
keto (n=3). Barplot indicate the molar fraction of 7-keto in 7-keto treated neurospheres and 
vehicle (DMSO) treated cells with error bars representing mean  ± S.E.M. Statistical 
significant difference was determined by Student t-test, *p<0.05. The correction of multiple 
comparisons was done by controlling the false discovery rate using the q value. !
On the other hand, 7-keto was also successfully incorporated into the 
neurospheres by DMSO vehicle (Figure 2-9). Different from what was found 
in the 24S-OH treatment, the lipid profile of 7-keto-treated neurospheres did 
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Figure 2-10. Effects of oxysterols in the proliferation of NSC-enriched neurospheres 
(n=6). (A) BrdU was used to label cells undergoing proliferation in neurospheres. BrdU 
positive cell number was normalized to DAPI positive cells and presented as the percentage 
value. (B) Sox-2 was used to indicate bona fide NSCs. Sox-2+ cell number was normalized to 
DAPI positive cells and presented as the percentage value. Error bars represent mean  ± 
S.E.M. *p<0.05. !
In the treatment of exogenous oxysterols, BrdU assay was employed to test the 
effect of these lipids in NSCs proliferative ability. Oxysterol treatment made 
BrdU positive cell frequency slightly downregulated in neurospheres exposed 
to 24S-OH and 7-keto, but the reduction was not significant. Sox-2 positive 
cell frequency in neurospheres appeared to show similar decreasing trend as 
BrdU+ cells, and moreover, the reduction of Sox-2 positive cells due to 7-keto 
treatment was statistically significant. The decreased NSCs frequency 
indicated by Sox-2 staining was consistent with reduced abundance of 7-keto 
during the NSC-enrichment of neurospheres, suggesting that this oxysterol has 
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Figure 2-11. Effect of 24S-OH in differentiation of NSC-enriched neurospheres (n=6). 
Neurogenesis and gliogenesis of neurospheres treated with 24S-OH was induced respectively. 
TUJ1 was used to label neurons (A, B), and GFAP was used to indicate astrocytes (D, E). 
Percentage of neurons (C) and astrocytes (F) was calculated to show the differentiation 
efficiency. Barplots represent the percentage of neurons and astrocytes in DMSO and 24S-OH 
treated cells. Error bars represent mean  ± S.E.M. Statistical significance was based on 
Student t-test, *p<0.05. Scale bar: 200µm. 
 
On the other hand, the effect of oxysterols in NSCs differentiation was 
verified in differentiation assay. The number of neurons differentiated from 
24S-OH treated neurospheres was dramatically decreased compared with 
vehicle (Figure 2-11. A). In contrast, the gliogenesis was not affected by 
introducing 24S-OH, as the percentage of GFAP positive cells did not change 
remarkably (Figure 2-11. B). Considering that the oxysterol supplementation 
in NSC-enriched neurospheres was performed before inducing the 
differentiation, the reduction of neurons in 24S-OH treated cells was possibly 
due to the fate-decision process rather than the neurotoxicity effect of 24S-OH. 
7-keto was also introduced in differentiation culture system, but no dramatic 
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2.4 Discussion 
The neurosphere assay provides us a useful in vitro system to investigate 
crucial attributes of NSCs. The heterogeneity nature of neurospheres may 
bring unexpected difficulties in studying bona fide NSCs, but the cellular 
content of neurospheres could be controlled by optimizing the culture 
condition. The frequency of bona fide NSCs was gradually increased in this 
study. The optimized neurosphere system allowed to analyze and compare the 
lipid content of NSCs with other progenitors and differentiated cells, revealing 
more information about the structural difference, or even implying the 
unknown mechanisms of NSCs proliferation and differentiation. 
 
2.4.1 Lipid metabolism in NSC-enriched neurospheres 
Lipid profile indicated that a few lipid subclasses were altered significantly 
during the NSC-enrichment of neurospheres (Figure 2-2), suggesting that the 
lipid metabolism in NSCs might be differentially regulated in contrast to 
progenitors and differentiated cells. Indeed, many genomics and proteomics 
studies tried to unveil the factors that maintain the “stemness” of NSCs, and 
showed that the expression of a few genes and enzymes involved in lipid 
metabolism were changed in NSCs. Here I combined lipidomics data with 
previous studies that illustrated the distinctly regulated gene [161-164, 167, 
168, 182] and protein [165, 166, 183-185] levels between NSCs and 
progenitors or differentiated cells, to propose a comprehensive lipid 
metabolism network in NSCs.  
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Figure 2-12 (Page 54). Proposed lipid metabolism network that is differentially regulated 
in NSCs compared with fate-committed progenitors and differentiated cells. This 
metabolism network is adapted from Kyoto Encycopedia of Genes and Genomes (KEGG), 
and derived from lipidomics data, genomics data [161-164, 167, 168, 182] and proteomics 
data [165, 166, 183-185]. Dark blue: downregulated; red: upregulated; black: no change; grey: 
unidentified; light blue: proposed downregulated; pink: proposed upregulated. Lipids: 
phosphatidylcholine (PC), glycerol 3-phosphate (glycerol-3P), 1-acyl-sn-glycerol 3-phosphate 
(AGPA), CDP-diacyl-glycerol (CDP-DG), phosphatidylinositol (PI), phosphatidylglycerol 
(PG), lysophosphatidylglycerol (LPG), lysobisphosphatidic acid (LBPA), phosphatidylserine 
(PS), phosphatidylethonalamine (PE), diacyl-glycerol (DAG), triacylglyceride (TAG), 
phosphoethonalamine (PEtn), fatty acid (FA), sphingosine-1-phosphate (S1P), ceramide (Cer), 
sphingomyelin (SM), glucosylceramide (GluCer), galactoceramide (GalCer), sulfatide (SL), 
cholesterol (ChoL), cholesteryl ester (CE),7!, 27-Dihydroxycholesterol (7!-27-diOH), 24S-
hydroxy-cholesterol (24S-OH), 7-keto-cholesterol (7-keto) and 7-hydroxycholesterol (7-OH). 
Proteins: glycerol-3-phosphate acyltransferase (GPAM), lysophosphatidylglycerol 
acyltransferase (LPGAT), lysophospholipase III (LYPLA3), lecithin-cholesterol 
acyltransferase (LCAT), phosphatidic acid phosphatase type 2B (PPAP2B), diacylglycerol O-
acyltransferase 2 (DGAT2), acid ceramidase (ASAH1), sphingomyelin phosphodiesterase 1 
(SMPD1), Hexosaminidase A (HEXA), acyl-CoA synthetase long-chain family member 5 
(ACSL5), carnitine palmitoyltransferase 1A (CPT1A), acyl-CoA dehydrogenase (ACADM), 
acyl-CoA oxidase (ACOX), acetyl-CoA acyltransferase 1/2 (ACAA1/2), long-chain-acyl-CoA 
dehydrogenase (ACADL),  very long-chain-acyl-CoA dehydrogenase (ACADVL), 3-
hydroxyacyl-CoA dehydrogenase (HADH), fatty acid synthase (FASN), acetyl-CoA 
carboxylase alpha (ACACA), stearoyl-CoA desaturase 2 (SCD2), peroxisomal trans-2-enoyl-
CoA reductase (PECR), acyl-CoA thioesterase 1, mitochondria (MTE1), acyl-CoA 
thioesterase 1, cytoplasma (PTE1), acetyl-CoA acetyltransferase 1 (ACAT1), cholesterol 
24(S)-hydroxylase (CYP46) and oxysterol 7-alpha-hydroxylase (CYP7B1). !
The proposed lipid metabolism network (Figure 2-12) revealed a general 
accumulation in most of the phospholipid subclasses, possibly suggesting an 
upregulation in fatty acid as a major component channeled into phospholipids. 
Indeed, it has been shown that fatty acid synthase (Fasn) expression was 
upregulated in proliferating NSCs but decreased after differentiation. Fasn 
exhibited higher enzymatic activity in NSCs than other neural cells. The 
impaired neurogenesis in Fasn-deleted mouse indicated the functional 
correlation between fatty acid metabolism and NSCs proliferation [186]. The 
changes in Lypla3 that catalyzes the conversion from PC to glycerol-3P 
suggested the alterations in glycolysis and glucogenesis in NSCs, in line with 
the different expression levels of relevant enzymes involved in glucose 
metabolism. In contrast, the abundance of a few sphingolipid subclasses (i.e. 
Cer, GluCer and SL) was reduced in NSCs, possibly resulting from the 
decreased biosynthesis of Cer from upstream. The unchanged SM amount 
could be explained as a result due to the reciprocal alteration of PC and 
SMPD1. Moreover, sterol synthesis was downregulated in NSCs, indicated by 
decreased ChoL and all oxysterols detected. Sterol biosynthesis is correlated 
  47 
with fatty acid degradation, as acetyl-CoA, the product of !-oxidation, serves 
as a precursor of ChoL. Indeed, a few enzymes facilitating !-oxidation in 
mitochondria or peroxisome were downregulated in NSCs. Besides, sterols 
and fatty acid metabolism interact via SREBPs. SREBPs control ChoL 
homeostasis by binding to sterol response elements (SRE) that participate in 
the transcriptional process of relevant receptors and synthase; on the other 
hand, SREBPs were found to interact with Fasn promoter and stimulate 
acetyl-CoA carboxylase (ACC). ChoL and fatty acid regulate the maturation 
and proteolytic process of SREBPs via feedback pathway [187]. Notably, 
APOE and LRP1 were upregulated in NSCs [188]. Both genes are involved in 
ChoL transportation and homeostasis. Apolipoprotein E, encoded by APOE, 
can bind lipid to form lipoproteins to facilitate intracellular lipid transportation 
via LRP1 mediated mechanism [137]. The upregulation of both genes in NSCs 
implied that the extracellular transfer of ChoL was possibly promoted in NSCs 
compared with fate-committed cells. The reduction of ChoL during the NSC-
enrichment in neurospheres might reflect a higher ChoL efflux rate in NSCs. 
The decrease of 24S-OH agreed well with the downregulated expression of 
CYP46 in NSCs. Notably, several other ChoL oxidases (e.g. CYP7B1) and 
downstream enzymes (i.e. HSD17B4) were also downregulated, implying the 
important role of sterol metabolic pathway in NSCs proliferation and 
differentiation. In parallel, CE was also reduced during the NSC-enrichment 
of neurospheres. The decrease of CE suggested that lower inner ChoL content 
is packed in lipid particles [189]. 
The proposed metabolism network summarizing genomics, proteomics and 
lipidomics data provides us with a general idea about the regulation of lipid 
metabolism in NSCs. Though more verification experiments need to be done, 
it is an important basis for further investigation in NSCs proliferation and 
differentiation. 
 
2.4.1.1 Effect of oxysterol treatment in sterols metabolism in NSC-enriched 
neurospheres 
24S-OH treatment in NSC-enriched neurospheres revealed a significant 
reduction in ChoL. This result was in accord with the downregulation in 
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members of the cholesterol/isoprenoid synthesis pathways induced by the 24S-
OH treatment in neurons, including acetoacetyl-CoA thiolase, HMG-CoA 
synthase, farnesyl-diphosphate synthase, squalene synthase and methylsterol 
monooxygenase, which are regulated by SREBPs [190]. Besides, APOE was 
upregulated in the same study, implying that 24S-OH regulated ChoL storage 
and transportation via LXR mediated signaling pathway [191]. However, 
ChoL volume did not change strikingly in 7-keto treated neurospheres. One 
explanation could be that 7-keto is not the primary downstream product of 
ChoL in the brain [177]; hence the suppression effect of this oxysterol in 
ChoL synthesis is not as strong as 24S-OH, whereby the feedback regulation 
was dominated. Thus, the metabolism of ChoL and some of its derivatives was 
closely regulated in NSCs. Perturbation in one oxysterol could alter other lipid 
species in sterol metabolic pathways. However, this effect is isomer-specific, 
and the underlying mechanism is not known yet. 
 
2.4.1.2 Effect of oxysterol treatment in phospholipids metabolism in NSC-
enriched neurospheres 
In addition to the alteration in ChoL and its derivatives, most diacyl-PC 
individual species as well as the diacyl-PC subclass were also dramatically 
upregulated in 24S-OH treated NSC-enriched neurospheres (Figure 2-8). It 
has been reported that several oxysterols (i.e. 22-, 25-, and 27-
hydroxycholesterol) could promote PC synthesis as a result of 
CTP:phosphocholine cytidylyltransferase ! (CCT!) translocation and 
activation at the nuclear membranes [192]. On the contrary, other studies 
revealed the inhibiting effect of 25-hydroxycholesterol (25-OH) in PC 
synthesis at the same step catalyzed by CCT [193]. Besides, the activity of 
CCT could be stimulated by ChoL in a post-transcriptional manner [118, 119] 
and suppressed competitively by isoprenoid intermediated (i.e. farnesol) in the 
ChoL biosynthetic pathway [194, 195]. Thus, the elevation of PC induced by 
24S-OH in NSC-enriched neurospheres was likely to be a coordinated result 
between several lipid species in sterols metabolism. Moreover, the amounts of 
diacyl-PC and ChoL were reciprocally regulated in both non-oxysterol and 
24S-OH-treated neurospheres, showing a remarkable accumulation of diacyl-
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PC coincident with the reduction of ChoL. As the two major component of 
plasma membrane, the changes in PC and ChoL possibly suggested the 
alterations in membrane rigidity and fluidity, as well as packing and 
transporting capacity of phospholipids [196]. Therefore, alterations in 
oxysterols led to changes not only in sterols, but also in phospholipids. The 
large scale of lipid alterations affirms the importance of systematic lipidomics 
study in NSCs. 
 
2.4.2 Redox state regulating NSCs proliferation and differentiation 
An emerging idea indicates that energy metabolism and redox state are critical 
modulators in NSCs fate decision processes. As mentioned earlier, NSCs that 
stay in a more oxidative environment preferentially undergo differentiation 
rather than remain multipotent [111]. The differentiation of NSCs can be 
enhanced by oxidation, while reduced state maintains the proliferating 
precursor cells [85, 86]. Thus, it could be expected that as a pivotal component 
in energy and redox state, the metabolism especially the oxidation of lipids 
could account for the energy and redox regulation in NSCs differentiation. In 
general, the lipid metabolism in the proposed network agreed with the redox 
state theory in NSCs. The increased of unsaturated phospholipids is highly 
possible to maintain the NSCs in a more reduced environment. Furthermore, 
downregulated fatty acid oxidation as well as the following attenuated ChoL 
oxidation also indicated the less oxidized state in NSCs compared with 
progenitors and differentiated cells. Therefore, the lipid metabolism in NSCs 
accommodated its stemness property by modulating the redox state, and 
maintained NSCs in self-renewing instead of differentiating. 
 
2.4.3 Effect of sterols and PC in NSCs proliferation and 
differentiation 
The alteration of oxysterols during the NSC-enrichment of neurosphere and 
their effect in NSC-enriched neurospheres indicated the regulating roles of 
these biological active molecules. The reduction of NSCs induced by 7-keto 
supplementation in NSC-enriched neurospheres was consistent with its 
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varying trend during the NSC-enrichment in neurospheres. Besides, 7-keto-
treated neurospheres did not show significant alteration in differentiation. This 
evidence implied that 7-keto downregulated the proliferation or survival 
without affecting the differentiation of NSCs. In corroboration with this 
observation, introduction of 7-keto or some other oxysterols would inhibit the 
proliferation [197], or lead to apoptosis or necrosis in different types of neural 
cells (i.e. SH-SY5Y and NT2) [198, 199]. 
24S-OH did not affect the proliferation of NSC-enriched neurospheres in this 
study. However, the neurogenesis from neurospheres was impaired by 24S-
OH. In contrast to this result, it has been showed that midbrain neurogenesis is 
promoted by another oxysterol 22-hydroxycholesterol (22-OH) via LXR 
mediated mechanism [200]. The distinct effects of different oxysterols 
suggested their regulating effect might be due to the dosage performed, the 
organisms employed and the isomer-specificity. As mentioned earlier, the 
lipidomics analysis after the oxysterol treatment revealed a broader lipid 
alteration induced by a single lipid supplementation, even if the amount of the 
lipid added was relatively small in the total lipids pool. Previous studies and 
conclusions based on similar treatment strategy should be re-considered and 
evaluated if the whole lipid content was not analyzed at a system level. The 
diversity of lipids and complicity of metabolism network could be an 
explanation for the contradiction of oxysterols effect reported earlier. 
Therefore, the anti-neurogenesis effect of 24S-OH in NSC-enriched 
neurospheres is likely to be a result of the coordination between 24S-OH, 
ChoL and PC. As both structural and signaling component, ChoL has multiple 
roles in survival and growth of NSCs, and even in further axonal and dendritic 
growth of neurons. For examples, inhibition of ChoL synthesis impairs the 
brain development due to the apoptosis of massive newborn neurons [132], 
while ChoL depletion enhances the neurite outgrowth and promotes neuronal 
polarity in hippocampal neurons [201]. On the other hand, neurospheres 
treated with a PC-specific phospholipase C inhibitor exhibited a suppressed 
proliferation by affecting the process of cell cycle [202]; besides, neurogenesis 
can be promoted during the retinoic acid (RA)-induced Neuro-2a cells 
differentiation, by enhanced PC synthesis that mimics RA signals [203]. 
However, the elevated PC amount in enhanced proliferation and decreased 
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neurogenesis observed here are contradictory to previous conclusions. 
Therefore, the reciprocal alterations of ChoL and PC might be responsible for 
the phenomenons observed rather than due to their individual functions. 
Considering that 24S-OH treatment did not affect the proliferation of NSC-
enriched neurospheres (Figure 2-10), the downregulation of ChoL together 
with the accumulation of PC was likely to maintain NSCs in a quiescent and 
undifferentiated state, and further suppress the ability to generate neurons. Yet 
the underlying mechanism has not been revealed. An explanation could be that 
the changes in the ratio of ChoL over PC may influence the structure and 
function of lipid rafts in membranes, which is providing a platform for many 
signaling pathways regulating NSCs proliferation and differentiation. 
 
2.4.4 Effect of sphingolipids in NSCs proliferation and 
differentiation 
In past decades, more attention has been paid to small molecule sphingolipids, 
such as Cer and its derivatives. These lipid species serve as second messengers 
in several pathways regulating neural cell survival, proliferation and 
differentiation. Cer mediated apoptosis has been observed in PC12 cell lines 
[204-206], and the exogenous Cer also exhibits similar apoptotic effect [207]. 
It has been proved that Cer induced neural cell apoptosis by activating diverse 
pro-apoptotic proteins such as JNK, Bax and p38, while on the other hand, 
some neuronal survival pathways were inhibited [208]. Besides, the 
differentiation of neuroblastoma or glioma cells can be enhanced by Cer, 
whereas the proliferation is suppressed [209-211]. The reduction of Cer during 
the NSC-enrichment of neurospheres here supported its pro-apoptotic and 
inhibiting proliferation effects in neural multipotent cells. Furthermore, 
evidence implies that the equilibrium and relative ratio between Cer and other 
sphingolipids, rather than the abundance of Cer alone, is the key factor in 
maintaining normal neuronal function. Though gangliosides were not detected 
here, its upstream GluCer and several synthase were downregulated in NSC-
enriched neurospheres. Thus, gangliosides probably followed the decreasing 
trend of other sphingolipids. The dominant decrease of Cer and its derivatives 
during the NSC-enrichment of neurospheres led us speculate that these lipids 
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are likely to be accumulated and more active during the differentiation instead 
of self-renewal in NSCs, and tend to push NSCs into differentiated status. 
 
2.4.5 Other notable lipid changes involved in effects in NSCs 
proliferation and differentiation 
Lipid profile revealed an early increase of LBPA during the NSC-enrichment 
of neurospheres, whereas the lipid content did not change significantly 
afterwards. This alteration kept pace with the decrease of NPCs and neurons at 
the early stage. LBPA is localized exclusively within the internal membranes 
of late endosomes, and had been implicated in specifically sorting lipids either 
for lysosomal degradation or plasma membrane recycling [212]. The 
interactions between neuronal death and proteins regulating endosomal 
trafficking [213] allow us to link the massive cell death of progenitors and 
differentiated cells with the elevation of LBPA, implying that endocytic 
trafficking is involved in neuronal cell death. 
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2.5 Conclusion 
In this chapter, the comprehensive lipid profiles during the enrichment of 
NSCs were analyzed for the first time. In combination with previous genomics 
and proteomics studies, a network was proposed based on lipidomics data to 
show the differentially regulated lipid metabolisms in NSCs compared with 
fate-committed progenitors and differentiated neural cells. Some of the lipid 
metabolic pathways might be correlated with the stemness properties of NSCs. 
This systematic study provides us an important basis for further investigation 
in NSCs proliferation and differentiation. Oxysterol treatment in NSC-
enriched neurospheres further supported that several lipid species are closely 
regulated in NSCs. The widely altered lipid abundance due to the perturbation 
of one lipid species indicates that it is more meaningful to discuss the effect of 
lipids from a comprehensive systematic view, instead of focusing on a single 
individual species. 
The elevation of unsaturation and decreased oxidation of lipids implied a more 
reduced environment in NSCs compared with progenitors and differentiated 
cells, which maintained NSCs in self-renewing instead of differentiating. 24S-
OH induced down-regulation of ChoL, accompanied by the upregulation of 
diacyl-PC. This observation together with the lipid alteration during the NSC-
enrichment implied the reciprocal regulation of ChoL and diacyl-PC was 
responsible for maintaining the undifferentiated state of NSCs. Besides, the 
reduction of NSCs in the 7-keto treatment, in line with its decreasing trend 
during the NSC-enrichment, suggested the inhibition effect of 7-keto in NSCs 
survival or proliferation. On the other hand, many sphingolipids exhibited 
downregulation during the enrichment of NSC, including Cer, GluCer and SL. 
The predominant decrease of these sphingolipid species implied their negative 
effect in maintaining the undifferentiated state of NSCs, and probably these 
bioactive signaling molecules are preferentially directing NSCs into 
differentiation. 
Taken together, this chapter reveals various potential roles of different lipid 
species during the proliferation and differentiation in NSCs. 
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3. Lipidomics analysis of neurons at different 
developmental stages and astrocytes 
3.1 Introduction 
In addition to the capacity of self-renewal, another essential feature that 
characterizes NSCs is the ability to differentiate into distinct types of neural 
cells [5]. As the major component of the brain, neurons and glial cells both 
have their own properties and functions. A neuron, which consists of a cell 
body, an axon, a dendrite and other fine structures such as dendritic spines and 
synapses, is usually considered as the most important functional unit in the 
brain. It is responsible for the release of neurotransmitters and electrical signal 
transduction to further control higher level of neuroactivity (e.g. memory). 
Therefore, the generation and growth of fate-specific and functional neurons 
are crucial for both normal and aberrant (e.g. traumatic injury or 
neurodegenerative disease) development of the brain. On the other hand, glial 
cells have different morphological characteristics, termed as a type of “glue” 
that fills the interstitial space when it was first observed [214]. Though 
occupying a substantial amount of space in the brain, glial cell was previously 
thought to exert only structural and neurotrophic functions in supporting 
neuronal growth in the brain. However, accumulating evidences reveal that 
glial cells are not only functioning as a structural and trophic component in the 
brain, but also interact with neurons to facilitate the comprehensive neural 
network [215]. Astrocyte-secreted neuromodulators such as growth factors, 
enzymes and lipid transporting proteins, are necessary for neuronal survival, 
and regulate further neuronal growth, such as neurite growth, axonal 
formation, and even synaptic transmission [216-219]. Comprehensive 
genomics and proteomics studies in neurons and astrocytes [220-222], even 
the analysis of secretome by astrocytes has been done by different groups [223, 
224], to decipher the complicated language between glial cells and neurons. 
Studies focusing on metabolites illustrate that energy metabolism during 
synaptic activity is regulated by astrocytes, as astrocytic energy is provided to 
neurons by metabolites transportation such as glutamate [225]. 
However, less attention was paid to another essential metabolic molecule, the 
  55 
lipid. Several reports revealed the synthesis and transportation of 
phospholipids, sphingolipids and sterols during the growth of neurons or glial 
cells respectively [122, 136, 226]. Though a few evidences unveil the lipid 
communication between neurons and glial cells, most of them are limited to 
certain subclasses of lipid species [227]. The lack of comprehensive 
lipidomics studies with molecular signature details restricts the view to 
illustrate the properties and interactions of these two types of neural cells 
structurally and functionally. Promising research directions could be 
unmasked by lipidomics analysis, as it is an indispensable approach to identify 
lipids with regulating roles from a large body of candidates. 
In this chapter, we performed a comparative and detailed lipidomics study for 
the first time between neurons and glial cells, as well as an analysis in 
dynamic alterations of lipid profile during the neuronal growth, to unveil the 
distinction in structure and function of these two types of neural cells. This 
work could also suggest the potential fate-deciding factors in NSCs. Moreover, 
the lipidomics study in medium cultured with different neural cells may reveal 
the roles of lipid in extracellular communication.  
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3.2 Materials and Methods 
3.2.1 Animal handling and collection of brain tissue 
As described in Chapter 2. 
 
3.2.2 Neuron-glia co-culture 
Protocol was adapted from Kaech S et al. [228] and Jones EV et al. [229]. 
Preparing coverslips and culture plates for co-culture 
Coverslips were washed by 70% nitric acid overnight. The following day, 
coverslips were washed by distilled water for three times. Sterilization was 
done by rinsing coverslips in absolute ethanol and drying in tissue culture 
hood. Three days prior to dissection, 100mm culture plates or coverslips were 
coated with 5mL of 1mg/mL poly-L-lysine and left overnight in cell culture 
incubator (37°C). Culture plates or coverslips were washed twice with sterile 
distilled water in 37°C. After that, coverslips and plates were coated with 
0.1mg/mL laminin for at least 1 hour in incubator, following with washing by 
sterile PBS for 2 hours in incubator. PBS was replaced by glial growth 
medium or neuronal growth medium conditioning for 1-2 days before 
dissection. Glial growth medium: minimum essential medium containing 
Earle’s salts and L-glutamine (Invitrogen 11095-080), 10% fetal bovine serum 
(Invitrogen), 0.6% glucose (v/v). Neuronal growth medium: neurobasal 
medium (Invitrogen 21103049), 1% GlutaMax (Invitrogen 35050061), 2% B-
27 (Invitrogen 17504044). 
Preparation of the astrocyte feeder layer 
Cortical tissues isolated from E14 mice brains were treated with 0.5% trypsin-
EDTA for 15 minutes in cell culture incubator, and washed by glial growth 
medium for twice. Cells were seeded in 100mm culture plate at the density of 
2!105, and placed in incubator at 37°C, 5% CO2. Medium was fully changed 
every three days. At cell confluence of 50% (approximately seven days later), 
the astrocytes were ready to be transferred. Cells were washed by sterile PBS 
and treated with 0.5% trypsin-EDTA in 37°C for 10 min, followed by washing 
with glial growth media twice at 1,500 rpm for 5 min. Astrocytes were seeded 
on a new poly-L-lysine and laminin-coated plate, and allowed to attach for 1 
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day. 24 hours prior to dissection of neurons, glial growth medium was 
changed to neuronal growth medium. 
Preparation of mouse cortical neurons 
Cortical tissue collection was described in Chapter 2. Cells were plated at a 
density of approximately 3,000 cells per 25-mm coverslip, and allowed to 
attach for 30 min. Coverslips were removed and placed on the top of astrocyte 
feeder layer with neurons facing up. Neurons and astrocytes were incubated in 
37°C, 5 % CO2, and the medium was half-changed every 4 days. 
 
3.2.3 Neuronal or glial culture 
Protocol was described as above. Neurons and glial cells were incubated in 
different culture system respectively. Glial cells were first cultured in glial 
growth medium, and transferred into neuronal growth medium after 7 days. 
Medium was half-changed and collected every 4 days as it is done in 
neuronal/co-culture system. 
 
3.2.4 Lipid extraction from cell culture medium and lipid analysis 
Neuronal growth medium from neuronal/glial/co-culture system was collected, 
and clean medium without cells was considered as blank. Cell culture medium 
was centrifuged and supernatant was allocated as 1mL. 0.75mL butanol 
(Sigma) was added into 1mL medium and mixed well. Mixture was kept in -
80°C overnight. The next day medium was agitated at 1,100 rpm with 
thermomixer at 4°C for 1.5h, and centrifuged at 4,600 rpm for 20 min at 4°C. 
Top phase was transferred into a glass vial. Re-extraction was performed by 
adding 1mL chilled choloroform and agitating at 1,100 rpm for 1h at 4°C. 
Samples were centrifuged at 4,600 rpm for 30 min at 4°C, and bottom organic 
phase was transferred into a glass vial. Lipid samples were dried under 
nitrogen stream and resuspended in the solvent (choloroform:methanol, 1:1 
(v/v)) for further analysis. 
Lipid extraction from cells and lipid analysis were described in Chapter 2. 
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3.2.5 Lipidomics data processing 
MRM data were extracted by Analyst Software (Applied Biosystems, Foster 
City, CA, USA). The amounts of lipid classes and individual species were 
normalized by the spiked standard concentration, and then normalized to total 
lipid composition. Molar fractions were used for further analysis. One-way 
ANOVA with post-hoc Tukey’s test was performed to compare the changes in 
lipid profiles between different types of cells (i.e. N, GNN, GNG and G) 
/medium (i.e. Blank, MN, MGN and MG) or different time points (i.e. 12h, 
36h, Day 4, Day 8 and Day 12), the correction of multiple comparisons was 
done by controlling the false discovery rate using the q value (R 3.0.1). 
ANOVA with post-hoc Tukey’s test and correction was done with the help 
from Xinrui Duan. Data was clustered by hierarchical clustering using Pearson 
correlation distances (centered) with average-linkage (Cluster 3.0), and 
viewed by Java Tree View. 
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3.3 Results 
3.3.1 Cell frequencies in neuronal and astrocyte layer 
Neurons and astrocytes were either cultured separately or together in 
neuronal/glial/neuron-glia co-culture systems. The frequencies of different 
types of neural cells were quantified by neuron and astrocyte markers. 
 
Figure 3-1. Cell frequencies in astrocyte and neuron layers (n=6). Neurons were stained 
by the anti-TUJ1 (red) antibody, and astrocytes were stained by the anti-GFAP (green) 
antibody. Cell frequencies of both types of cells were normalized to the number of DAPI 
positive cells. Scale bar: 200µm. Error bars represent mean  ± S.E.M. !
Neuron and astrocyte staining markers indicated that the astrocyte feeder layer 
was dominated by astrocytes. On the other hand, the neuron layer was 
dominated by neurons, indicating that the lipid analysis based on this culture 
condition could reflect the properties of the particular type of neural cells with 
different nature. Neurons and astrocytes from single (i.e. neuronal culture and 
glial culture) and co-culture system were collected for further lipidomics 
analysis. 
 
3.3.2 Neuronal development in the co-culture system 
Furthermore, a time course study was performed to reveal the dynamic lipid 
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alterations during the neuronal growth. We focused on neurons in the neuron-
glia co-culture system, as this system with the existence of astrocytes is more 
physically relevant to the in vivo neuronal growth niche. Neuronal growth 
stages were defined by different neuronal markers. The double staining of 
immature (PSA-NCAM) and mature (NeuN) neuronal markers was performed 
to indicate neuronal developmental stages. PSA-NCAM is usually used as an 
immature neuron marker [230], which is expressed from the initial stage of 
neuronal development, and sequentially downregulated at later stages. In 
contrast, NeuN does not appear at the very beginning of neuronal growth, 
while it is dominantly expressed in mature neurons [231]. The combination of 
these two markers clearly demonstrated the growth stage of neurons in the 
culture systems (Figure 3-2. K). 
Neurites began to sprout 12 hour later after cells were seeded on pre-coated 
coverslips (Figure 3-2. A and F). At 36 hours around, one of the neurites 
elongated as a potential axon (Figure 3-2. B and G). The axon continued to 
extend, and the dendrites appeared at Day 4 (Figure 3-2. C and H). A week 
after (Day 8), fine structures (e.g. spines and synapses) were formed, and the 
axon continued its extension (Figure 3-2. D and I). At Day 12, the formation 
of mature neuronal network was completed (Figure 3-2. E and J). Most 
neurons at early developmental stages (12h to Day 4) were PSA-NCAM 
positive, however, the PSA-NCAM signal was downregulated a few days later. 
Meanwhile, the cell frequency of NeuN positive neurons increased, indicating 
the maturation of neurons. Neurons from typical developmental stages (i.e. 
12h, 36h, Day 4, Day 8 and Day 12) were selected to illustrate the dynamic 
changes of lipid content and metabolism during neuronal growth. 
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Figure 3-2. Neuronal growth in the neuron-glia co-culture system (n=6). Neurons were stained by both anti-PSA-NCAM (red) and anti-NeuN (green) antibodies (A-E), 
indicating different developmental stages (12h, 36h, Day 4, Day 8 and Day 12). F-J: bright field of neuronal growth (12h, 36h, Day 4, Day 8 and Day 12). (K) Frequencies of 
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3.3.3 Comparative lipidomics analysis of neurons and astrocytes 
Lipid profiles in neurons and astrocytes were comparatively analyzed. Glial 
cells in each culture system from all developmental stages were considered as 
one glial population, as they kept dividing and their growth did not 
synchronize. Neurons at different developmental stages (12h to Day 12) were 
also treated as one population in this study, so as to get a general idea how the 
lipid composition altered between neurons and astrocytes. 
A total of 152 distinct lipid species from 12 lipid subclasses, including neutral 
lipids such as cholesteryl ester (CE), cholesterol (ChoL), 24S-
hydroxycholesterol (24S-OH), 7-keto-cholesterol (7-keto), and 7-
hydroxycholesterol (7-OH); sphingolipids including ceramides (Cer), 
glucosylceramides (GluCer) and sphingomyelins (SM); as well as 
phospholipid subclasses of phosphatidylcholines (PC), 
lysophosphaticylcholine (LPC), phosphatidylethanolamines (PE), 
phosphatidylglycerols (PG), phosphatidylinositols (PI), phosphatidylserines 
(PS) and lysobisphophatidic acids (LBPA) were analysed (Figure 4-2). 
Figure 3-3. Changes in lipids at the subclass level amongst neurons from neuronal 
culture (N) (n=36) and co-culture (GNN) (n=41), and astrocytes from co-culture (GNG) 
(n=41) and glial culture (G) (n=18). The abundance of lipid classes was normalized to total 
lipid composition and expressed as mean molar fractions with error bars indicating mean + 
S.E.M. Statistical significance among different types of cells was determined using one-way 
ANOVA with post-hoc Tukey test, and the correction of multiple comparisons was done by 
controlling the false discovery rate using the q value. *p<0.05, **p<0.01, ***p<0.001. 
 
Several lipid subclasses exhibited significant differences between neurons 
(GNN) and astrocytes (GNG) in the co-culture system, including PC, LPC, PE, 
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showed a dramatic change between astrocytes in the co-culture system (GNG) 
and glial culture system (G) (Figure 3-3). Lipid profile of neurons agreed well 
with the previous report that neuronal membrane is comprised of 58% PC, 24% 
PE, 8% PI, 5% PS, 3% SM and 20% ChoL [232]. 
Hierarchical clustering was next performed to generally show the alterations 
as well as the coregulations of lipids between those four types of neural cells 
at the individual species level. In general, the most striking changes were 
found between neurons (N and GNN) versus astrocytes (GNG and G) rather 
than the same type of cells from different culture conditions, which is in line 
with the result observed at the subclass level. For instance, Cluster 1-4 showed 
elevated lipid amounts in GNG compared to GNN. Cluster 1 was dominated 
by ePC species. Lipid species in Cluster 2 included all SM species, ePC (C36-
C40), PS (C34-C38), PI (C36-C38) as well as diacyl PE and PC species. 
Notably, the fatty acyl chain length of phospholipids in this cluster ranges 
from C36 to C40, implying that the enrichment of these phospholipids in 
astrocytes is fatty acyl heterogeneity dependent. A few PI species and ePCs 
(C36-C40) constituted Cluster 4. On the other hand, several clusters exhibited 
decreasing lipid amount in astrocytes, such as Cluster 5-7. Cluster 5 and 6 
contained several phospholipid species, including diacyl-PC, PE and PS, and 
all oxysterols and CE were grouped together in Cluster 7. Interestingly, ePC 
and diacyl-PC were separated and exhibited opposite alterations in neurons 
and astrocytes. Moreover, Cluster 3 with most of the LBPA revealed a 
dramatic difference between astrocytes from different culture systems (GNG 
and G). 
  64 
 
Figure 3-4 (A). Hierarchical clustering of lipid alterations amongst N (n=36), GNN 
(n=41), GNG (n=41) and G (n=18). The molar fraction of individual lipid species was 
plotted on a z-score color scale with blue representing low fold change and red representing 
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Figure 3-4 (B). Eight clusters were highlighted to demonstrate the lipid alterations 
amongst N (n=36), GNN (n=41), GNG (n=41) and G (n=18. The molar fraction of 
individual lipid species was plotted on a z-score color scale with blue representing low fold 
change and red representing high fold change. Grey line demonstrates the value of each 
species with black line illustrating the mean value of all species in each cluster. These eight 
clusters were highlighted demonstrating distinct types of alteration. Error bars represent mean  
± standard deviations. 
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3.3.3.1 Changes in phospholipids between neurons and astrocytes 
 
Figure 3-5. Comparative lipids profiles of phospholipids in GNN (n=41) and G (n=18). 
Heatmaps illustrate the fold changes in individual lipid species in GNN and GNG from the 
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over the mean value of both of them was plotted on a log10 color scale, with blue representing 
low fold change and red representing high fold change. Barplots indicate molar fractions of 
individual species of (C) LPC and (D) LBAP. Lipid abundance of individual species was 
normalized to total lipid composition and expressed as mean molar fractions with error bars 
indicating mean + S.E.M. Statistical significance among N, GNN, GNG and G was 
determined using one-way ANOVA with post-hoc Tukey test, and the correction of multiple 
comparisons was done by controlling the false discovery rate using the q value. *p<0.05, 
**p<0.01, ***p<0.001. 
 
Comparison analysis of PC between neurons and astrocytes revealed that 
diacyl-PC and ePC exhibited distinct types of enrichment in these cells. Most 
of the diacyl-PC showed higher amounts in neurons. On contrary, ePCs were 
enriched in astrocytes (Figure 3-4. B). Individual PE species exhibited the 
similar pattern as PCs, though the distinction between diacyl-PE and ePE was 
not as striking as that in PCs (Figure 3-4. B). In addition, ether LPC species 
(i.e. LPC 16:0e and 18:0e) were also found differentially regulated from 
diacyl-LPC (Figure 3-4. C), indicating that diacyl-LPC was predominantly 
elevated in astrocytes while ether LPC was decreased. Coinciding with the 
accumulation of total LBPA in GNG, all individual LBPA species were 
consistently enriched in astrocytes from the co-culture system (Figure 3-4. D). 
 
3.3.3.2 Alterations in sphingolipids between neurons and astrocytes 
In line with the appreciable accumulation of the total SM, molecular profiling 
demonstrated that all SM individual species were dramatically enriched in 
astrocytes (p<0.001) (Figure 3-5. A). Detailed molecular profiles illustrated 
that short-chain Cer (C16-C18) were significantly reduced in astrocytes, 
paralleled with the drastic decrease of short-chain GluCer (C16-C20) (Figure 
3-5. B and C). In contrast, long-chain Cer (C24) was increased accompanying 
with a non-significant reduction of long-chain GluCer (C22-C24). This chain 
length specific alterations of Cer is consistent with the differential expression 
level of ceramide synthase, as CerS1 that is responsible for C18-20 Cer 
synthesis is highly expressed in most neurons, while long-chain Cer synthase 
CerS2 is transiently expressed in glial cells [233]. The specific enrichment of 
short-chain Cer and GluCer in neurons implied that short-chain Cer was 
probably converted into GluCer with corresponding fatty acyl moieties, while 
the overall reduction in SM might have resulted from the attenuated 
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biosynthesis from Cer. 
 
Figure 3-6. Comparative lipids profiles of sphingolipids in GNN (n=41) and GNG (n=18). 
Barplots indicate molar fractions of individual species of (A) SM, (B) Cer and (C) GluCer in 
GNN and GNG. Lipid abundance of individual species was normalized to total lipid 
composition and expressed as mean molar fractions with error bars indicating mean + S.E.M. 
Statistical significance among N, GNN, GNG and G was determined using one-way ANOVA 
with post-hoc Tukey test, and the correction of multiple comparisons was done by controlling 
the false discovery rate using the q value. *p<0.05, **p<0.01, ***p<0.001. !
3.3.3.3 Reduction of ChoL and overall accumulation of oxysterols in neurons 
ChoL was enriched in astrocytes, while all oxysterols revealed significant 
higher amounts in neurons (Figure 3-3). Notably, CE was slightly reduced in 
astrocytes, in close agreement with other oxysterols (Figure 3-4. B “Cluster 
7”). The corresponding alteration of ChoL and its derivatives suggested that 
the elevation of oxysterols in neurons is highly possible due to the enhanced 
conversion from upstream ChoL. Moreover, the excess ChoL in astrocytes 
may probably serve as a ChoL pool that might be transported into neurons to 
support neuronal function [227]. 
 
3.3.3.4 Other notable lipid alterations in neurons and astrocytes 
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was interesting to find that the relative abundance of several lipid species was 
altered within the same type of neural cells. Astrocytes and neurons in the co-
culture system might affect the metabolism of lipid reciprocally, which may 
reveal more information about neuron-astrocyte communication during 
neuronal growth. 
Although total PC abundance did not change significantly, molecular profiles 
revealed that ePC and diacyl-PC were regulated differentially and altered 
dramatically in two types of neurons. ePCs were predominantly accumulated 
in GNN (Figure 3-6. A and C), yet most diacyl-PCs were elevated in N 
(Figure 3-6. B and C). This observation agreed with the clustering results 
again, showing that ePC and PC were differentially regulated in neurons and 
astrocytes (Figure 3-3). Besides, LPC species were consistently enriched in 
GNN. 
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Figure 3-7. Comparative lipids profiles of phospholipids in N (n-36) and GNN (n=41). 
Heatmap illustrates the fold changes in individual lipid species in N and GNN from the 
subclasses of plasmalogen PC and diacyl-PC (C). The ratio of N or GNN over the mean value 
of both of them was plotted on a log10 color scale with blue representing low fold change and 
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(A) ePC, (B) diacyl-PC and (D) LPC between N and GNN. Lipid abundance of individual 
species was normalized to total lipid composition and expressed as mean molar fractions with 
error bars indicating mean + S.E.M.  Statistical significance among N, GNN, GNG and G was 
determined using one-way ANOVA with post-hoc Tukey test, and the correction of multiple 
comparisons was done by correcting the false discovery rate using the q value. *p<0.05, 
**p<0.01, ***p<0.001. 
 
Figure 3-8. Comparative lipids profile of LBPA in GNG (n=41) and G (n=18). . Lipid 
abundance of individual species was normalized to total lipid composition and expressed as 
mean molar fractions with error bars indicating mean + S.E.M. Statistical significance among 
N, GNN, GNG and G was determined using one-way ANOVA with post-hoc Tukey test, and 
the correction of multiple comparisons was done by controlling the false discovery rate using 
the q value. *p<0.05, **p<0.01, ***p<0.001. !
As the only lipid class showed a significant difference between two types of 
astrocytes, all individual LBPA species were remarkably upregulated in co-
cultured astrocytes (GNG). The crucial role of LBPA in late endosome 
implied that this subcellular organelle and its relevant cellular function might 
be involved in neuron-astrocyte communication during neuronal growth. 
 
3.3.4 Time course study of lipid alterations in neurons during 
neuronal development in the neuron-glia co-culture system 
Comparative lipidomics analysis between astrocytes and neurons revealed the 
differentially regulated lipid metabolism in these two major types of neural 
cells in the brain. Furthermore, a more detailed and precise lipid profile is 
required to explore the role of lipid during the dynamic neuronal development. 
Five typical developmental stages of neurons from the co-culture system were 
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Figure 3-9 (A). Hierarchical clustering of lipid alterations during neuronal growth. (12h 
(n=8), 36h (n=6), Day 4 (n=9), Day 8 (n=9), Day 12 (n=9). The molar fraction of individual 
lipid species was plotted on a z-score color scale over the whole time frame with blue 
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Figure 3-9 (B). Eight clusters were highlighted to demonstrate distinct types of 
alterations during neuronal growth. (12h (n=8), 36h (n=6), Day 4 (n=9), Day 8 (n=9), Day 
12 (n=9). The molar fraction of individual lipid species was plotted on a z-score color scale 
over the whole time frame with blue representing low fold change and red representing high 
fold change. Grey line demonstrates the value of each species with black line illustrating the 
mean value of all species in each cluster. Error bars represent mean  ± standard deviations. 
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The lipid profile alterations in neurons during neuronal growth in the neuron-
glia co-culture system were categorized into eight interesting clusters, most of 
which did not show a consistent trend during the neuronal growth. Generally, 
the most striking changes happened between 36h and Day 8, while the lipid 
content did not alter a lot at the very beginning or the end stage, which is in 
line with the cellular composition change indicated by neuronal markers 
(Figure 3-2). Lipids in Cluster 1 consistently decreased from 12h to Day 12. 
This cluster was predominantly comprised of PC species and several PE 
species, most of which were diacyl-PC/PE with unsaturated fatty acyl chains. 
All oxysterols were included in Cluster 2, as well as CE, suggesting the 
alteration and metabolism of these ChoL derivatives are closely linked. The 
most remarkable character of this cluster was the peak shape with the highest 
value at Day 4. Cluster 3 mainly included PG. Lipids in this cluster were 
downregulated from 36h to Day 12, while an early increase occurred between 
12h and 36h. Lipid concentration of Cluster 4 that contains several LPC 
species seemed fluctuating during the whole time range of neuronal growth. 
Similar to Cluster 2, Cluster 5 with most SM exhibited the highest peak value 
at Day 4. Cluster 6 was dominantly constituted by ePCs, which revealed 
gradually increased lipid amounts, especially from Day 8 to Day 12. Cluster 7 
with several ePC and ePE, as well as some PIs, appeared to show the similar 
pattern as Cluster 6, while the most dramatic upregulation happened between 
12h and Day4. Notably, the unsaturation degrees of fatty acyl chains in 
Cluster 6 and 7 are relatively low (1-4). All and only LBPAs were categorized 
into Cluster 8, showing a peak value at Day 4. 
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3.3.4.1 Changes in phospholipids during neuronal development 
 
Figure 3-10. Changes of phospholipids in GNN during neuronal growth. (12h (n=8), 36h 
(n=6), Day 4 (n=9), Day 8 (n=9), Day 12 (n=9). (A) Heatmap illustrates the fold changes in 
individual PC species during neuronal growth. The molar fraction of individual PC species 
was plotted on a z-score color scale over the whole time frame with blue representing low fold 
changes and red representing high fold changes. Barplots indicate molar fractions of total (B) 
ePC, (C) diacyl-PC, individual (D) LPC, (E) PG and (F) LBPA species in GNN during 
neuronal growth. Lipid abundance of individual species was normalized to total lipid 
composition and expressed as mean molar fractions with error bars indicating mean + S.E.M. 
Statistical significance between different time points was determined using one-way ANOVA 
with post-hoc Tukey test, and the correction of multiple comparisons was done by controlling 
the false discovery rate using the q value. *p<0.05, **p<0.01, ***p<0.001. !
In corroboration with hierarchical clustering result (Figure 3-8. B “Cluster 1 
and 6”), ePC and diacyl-PC were differentially regulated during the neuronal 
growth. Most of the ePCs were consistently elevated (Figure 3-9. A and B), 
whereas diacyl-PCs were decreased (Figure 3-9. A and C) from 12h to Day 12. 
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and Day 4. All LPCe were increased; on contrary, diacyl-LPCs were 
significantly reduced. Besides, molecular profiling demonstrated that the 
amounts of all PG species were dramatically promoted at 36h with the highest 
peak value, while they were downregulated later. (Figure 3-9. E). Similarly, 
peak values also appeared in all LBPA species at Day 4; however, LBPA 
levels did not change significantly afterwards (Figure 3-9. F). 
 
3.3.4.2 Alterations in sterols and sphingolipids during neuronal development 
 
Figure 3-11. Changes in sterols and sphingomyelins in GNN during neuronal growth. 
(12h (n=8), 36h (n=6), Day 4 (n=9), Day 8 (n=9), Day 12 (n=9). Barplots indicate molar 
fractions of (A) ChoL, 24S-OH, 7-keto, 7-OH, CE and individual (B) SM species in GNN 
during neuronal growth. Lipid abundance of individual species was normalized to total lipid 
composition and expressed as mean molar fractions with error bars indicating mean + S.E.M.  
Statistical significance between different time points was determined using one-way ANOVA 
with post-hoc Tukey test, and the correction of multiple comparisons was done by controlling 
the false discovery rate using the q value. *p<0.05, **p<0.01, ***p<0.001. !
The most significant accumulation in ChoL was observed between Day 4 and 
Day 8 (Figure 3-10. A). These two time points served as a threshold in ChoL 
amount as ChoL was not dramatically altered at other time points. However, 
all the oxysterols (24S-OH, 7-keto and 7-OH) and CE exhibited different 
changing patterns during neuronal growth. Relative abundance of these lipid 
species was downregulated from Day 4 to Day 12, while at earlier stages lipid 
amount fluctuated slightly. The diminishing amounts of oxysterols and CE 
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load was required at late stages of neuronal development. In addition, all SM 
species showed a striking enrichment at Day 4, and most of them dropped 
down significantly from Day 8 onwards (Figure 3-10. B). The remarkable 
accumulation of SM at Day 4 suggested that SM is essential for axon 
formation. 
 
3.3.5 Comparative lipidomics analysis of cell culture medium from 
different culture systems 
In addition to lipidomics analysis in neural cells, lipid profiles in culture 
medium from three culture systems (i.e. neuronal culture, glial culture and co-
culture), as well as the clean medium (Blank), were analyzed to uncover 
secreted factors that participate in neuron-astrocyte communication. A total of 
143 distinct lipid species from 12 lipid subclasses including neutral lipids such 
as cholesteryl ester (CE), free cholesterols (ChoL), 24S-hydroxycholesterol 
(24S-OH), 7-keto-cholesterol (7-keto), and 7-hydroxycholesterol (7-OH); 
sphingolipids including ceramides (Cer), glucosylceramides (GluCer) and 
sphingomyelins (SM); as well as phospholipid subclasses of 
phosphatidylcholines (PC), lysophosphaticylcholine (LPC), 
phosphatidylethanolamines (PE), phosphatidylglycerols (PG), 
phosphatidylinositols (PI) and phosphatidylserines (PS) were analysed. 
ChoL was significantly decreased in all cultured medium, accompanied by 
reductions of all oxysterols and CE (Figure 3-11. A). Moreover, 24S-OH 
showed higher amount in MN comparing to MGN, and 7-keto was 
accumulated in MGN in contrast to MG. 
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Figure 3-12. Comparative lipid profiles of sterols and phospholipids amongst different 
conditioned medium. (Blank (n=6), MN (n=39), MGN (n=38), MG (n=20)). Barplots 
indicate molar fractions of individual (A) ChoL, 24S-OH, 7-keto, 7-OH, CE, individual (B) 
PG and (C) PI species in Blank, MN, MGN and MG. Lipid abundance of individual species 
was normalized to total lipid composition and expressed as mean molar fractions with error 
bars indicating mean + S.E.M. Statistical significance between different types of medium was 
determined using one-way ANOVA with post-hoc Tukey test, and the correction of multiple 
comparisons was done by controlling the false discovery rate using the q value. *p<0.05, 
**p<0.01, ***p<0.001. !
Molecular profiling revealed that all PG species were strikingly reduced in 
cultured medium (Figure 3-11. B). Besides, several PG species with shorter 
fatty acyl chains (C34-C36) decreased significantly in MGN compared with 
MN, accompanied with a moderate or slight reduction of rest PGs. Individual 
PI species exhibited similar changing pattern, showing a dramatic reduction in 
all cultured medium and most of them were downregulated in MGN in 
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Figure 3-13. Changes in PG and sterols in MGN during neuronal growth. (Blank (n=6), 
12h (n=8), 36h (n=6), Day 4 (n=8), Day 8 (n=8), Day 12 (n=8)).Barplots indicate molar 
fractions of individual (A) individual PG species, (B) ChoL, 24S-OH, CE, and (C) 7-keto and 
7-OH in MGN during neuronal growth. Lipid abundance of individual species was normalized 
to total lipid composition and expressed as mean molar fractions with error bars indicating 
mean + S.E.M. Statistical significance between different time points was determined using 
one-way ANOVA with post-hoc Tukey test, and the correction of multiple comparisons was 
done by controlling the false discovery rate using the q value. *p<0.05, **p<0.01, 
***p<0.001. !
Time course study in co-culture medium (MGN) showed all PG species 
consistently decreased during the neuronal development. The most dramatic 
reduction of oxysterols happened between 12h and 36h. These alterations may 
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3.4 Discussion 
3.4.1 Alterations in lipid metabolism between astrocytes and 
neurons 
The alterations of major lipids (i.e. PC and ChoL) implied that, rather than 
synthesis of phospholipids, lipid metabolism pathway was pushed into ether 
lipids and sterol synthesis preferentially. Indeed, a comparative transcriptome 
study between astrocytes and neurons revealed that genes involved in fatty 
acid metabolism were highly enriched in astrocytes, while genes participating 
in fatty acid biosynthesis did not change dramatically [234]. Specifically, a 
few genes encoding enzymes promoting fatty acid !-oxidation were 
upregulated, including ECHS1, HADH and HADHB. The reduction of 
polyunsaturated PC and PE in astrocytes was in accord with the enhanced 
fatty acid degradation indicated by transcriptome study. This potentiated fatty 
acid metabolism was accompanied by the upregulation of enzymes at 
transcriptional level in ChoL biosynthesis pathway, led by the enhanced ChoL 
synthesis from upstream acetyl-CoA. For instance, HMGCR1/2, TM7SF2, 
SC4MOL, NSDHL, SC5D and DHCR7, together with SREBP1, were all 
upregulated; thus ChoL was elevated as we observed in astrocytes, while its 
oxidative derivatives reduced. The upregulation of genes encoding 
phospholipase A2 kept pace with the increased LPC in astrocytes, and the 
reciprocal alterations in diacyl and ether species of PC and LPC indicated that 
the regulations of these two types of lipids are relatively independent. In 
addition, the consistent elevation of all SM species in astrocytes seemed not 
completely in line with the chain length specific change of its upstream 
precursor Cer. Thus, the headgroup of diacyl-PC was possibly channeled into 
Cer, and converted to SM [235]. Notably, the only enriched lipid metabolic 
pathway in neuron is inositol phosphate metabolism [234], which might be 
reflected by the altered PI amount in cell culture medium. 
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3.4.2 Elevation of plasmalogen phospholipids and chain-length 
specific alterations in sphingolipids in the astrocyte implying its 
higher proliferative ability under oxidative stress 
Under oxidative stress due to traumatic injury or other pathological conditions, 
astrocytes as well as other glial cells exhibit much higher activity than neurons 
during the regeneration process, which results in an excess gliogenesis (e.g. 
glioscar) [236]. The highly proliferative and active gliosis severely hinders 
neurogenesis, and permanently impairs the function of the brain. Plasmalogens 
are believed to be antioxidants, as the vinyl ether bonds are more vulnerable to 
oxidation than the double bond found in polyunsaturated fatty acid. Hence, the 
oxidation of polyunsaturated glycerophosphlipids and ChoL can be blocked by 
plasmalogens, which are preferentially attacked by oxidants. Consequently, 
the normal cellular membrane structure is protected from oxidative stress [237, 
238]. The anti-oxidative effect of plasmalogen lipids allows us to link the 
enrichment of plasmalogen PC and PE in astrocytes with the higher 
susceptibility of astrocyte against oxidative stress. It is possible that the 
decreased oxysterols (Figure 3-2) in astrocytes kept pace with the reduced rate 
of ChoL oxidation due to plasmalogen [239]. Notably, plasmalogen PC was 
also elevated in neurons cultured with astrocytes than neurons cultured alone 
(Figure 3-6. A-C), probably suggesting the protective effect of astrocyte to 
neurons as an adaptive response. Besides, it has been proved that C24 Cer 
promotes proliferation [235], yet C16-C18 Cer exhibited an anti-proliferative 
effect [240], which is in accord with the chain length dependent alteration of 
Cer observed. These results implied that the accumulation of plasmalogen 
phospholipids makes astrocytes less vulnerable than neurons to oxidative 
stress, and chain-length dependent changes in Cer accommodate the higher 
proliferation ability of astrocytes. Consequently, neurogenesis and further 
axonal growth might be inhibited by astrocyte-secreted factors. Therefore, 
plasmalogen abundance in astrocytes could be a potential target to control 
gliosis under oxidative injury, and promote the regeneration of functional 
neurons sequentially. 
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3.4.3 Accumulation of LBPA in co-cultured astrocytes indicating 
the endosome-mediated intracellular transportation of ChoL 
between neurons and astrocytes 
The specific accumulation of LBPA in astrocytes from the co-culture system 
rather than glial culture system (Figure 3-7) led us to link this elevated lipid 
volume with neuron-astrocyte communication. Indeed, intracellular ChoL 
transportation exists, and the requirement of ChoL by neurons is partially 
fulfilled by astrocyte secretion. Excess ChoL produced by astrocytes can be 
released by APOE-containing lipoproteins via LDLR and the LRP1 mediated 
endocytosis [136]. Evidence has revealed the role of LBPA in ChoL 
transportation. The unconventional phospholipid LBPA is enriched in late 
endosomes, and regulates endosomal transportation of ChoL via Alix/AlP1 
[241]. When LBPA amount was decreased by Alix downregulation, ChoL 
amount is also reduced due to the affected ChoL storage capacity. The slightly 
higher 24S-OH abundance in GNG than G may reflect the feedback 
mechanism, signaling the neuronal ChoL amount to astrocytes [242, 243]. 
 
3.4.4 Membrane constitution and polarization during neuronal 
growth 
The growth of neuron is constituted by two major processes, firstly to build up 
the tree-like structure of the axons and dendrites, usually referred to as the 
plasma membrane structure formation, and secondly, to stabilize the re-
distribution and specialization in plasma membrane domains [244]. 
Numbers of lipids are required to support the extension of membrane structure, 
such as PC [122], ChoL and SM  [226] as the three major components of 
plasma membrane. The synthesis of different lipids is spatially regulated. For 
example, ChoL is exclusively synthesized in the cell body [245], while 
phospholipids synthesis is observed in both cell body and distal axons [120]. 
Our results revealed that SM was elevated at later stages concurrently with the 
accumulation of ChoL. These alterations might be related with the formation 
of dendritic spines and further maturation, which agreed with the requirement 
of these two lipids in dendritic spine and synapse formation indicated by 
  83 
previous study. It has been shown that the density of dendritic spines and 
synapses was decreased resulting from the depleted biosynthesis of SM and 
ChoL, which was depleted in hippocampal neurons [246]. The reduced 
oxidation and esterification of ChoL could be explained by the decreased 
catabolism, as a higher amount of ChoL was required at later neuronal growth 
stages. Another increase of SM was observed when axon elongation and 
dendrite formation occurred. It has been shown that the amount of SM, not 
ChoL or GluCer, was elevated in Day 7 neurons when cytoskeletal proteins 
and certain dendritic membrane proteins are underlying polarized distribution, 
which suggests that the formation of protein-lipid (SM and ChoL) complex is 
required for the proper polarization of axonal membrane [247]. The 
upregulation of SM observed in advance at Day 4 in this study implied that the 
preparation of SM may start even earlier than the membrane domain 
distribution, and the dendrite formation and polarization happened 
concurrently. 
Therefore, ChoL and SM are playing critical roles in membrane constitution 
and polarization during neuronal growth, and are likely to be co-regulated 
within certain developmental stages, whereas the relative abundance of PC in 
membranes might be adjusted accordingly. 
 
3.4.5 PG and LBPA alterations implying the involvement of 
endosome-mediated trafficking during neuronal growth 
The elevation of PG at 36h accompanied by its reduction in cell culture 
medium implied its involvement in neurite and axon formation. Meanwhile, 
LBPA was upregulated in accord with the accumulation of PG. It has been 
shown that PG could serve as a precursor for LBPA biosynthesis [248] though 
other pathways could not be excluded. The parallel upregulation observed 
during the early stage of neuronal growth suggested the metabolism of these 
two lipids might be co-regulated, and LBAP might be derived from 
endogenous or exogenous (culture medium supplementation) PG. Possibly, 
the accumulation of LBPA from 12 h to Day 4 coincides with the elevation of 
SM during axon elongation and dendrite formation, suggesting that LBPA-
enriched endosome is involved in membrane polarization. As mentioned 
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above, LBPA is enriched in late endosomes, participating in the trafficking of 
lipids and proteins [249]. Evidence showed that membrane materials supply, 
as well as further membrane polarization, was done via vesicle-mediated 
transportation between cell body, axon and synapse [116]. The existence of 
endosomal organelles in growth cones during neuronal growth [250] 
suggested the involvement of LBPA in axonal guidance and elongation. On 
the other hand, receptors for neuronal developmental signal transduction can 
be recycled by endosome [251].  Thus, it is likely that the elevations of PG 
and LBAP are related with the vesicle trafficking during the neuronal growth. 
Moreover, the stage-specific accumulation suggested that the reservoir of 
these lipids required by vesicle transportation had been established at the early 
stage, and it functions during the whole process of neuronal growth. 
 
3.4.6 Alterations of PI in cell culture medium suggesting its 
involvement in neuronal growth 
As aforementioned, inositol phosphate metabolic pathway is enriched in 
neurons compared with astrocytes [234]. PI and its derivatives 
(phosphoinositides) may play crucial roles in a variety of cellular functions, 
such as synaptic membrane trafficking [252].  As important signaling 
molecules, synthetic phosphoinositides were found to increase the number of 
neurites of PC12 cells [253]. Thus, the alteration of PI in cell culture medium 
may reflect its participation in relevant cellular processes, such as proliferation 
and membrane remodeling. The difference between MN and MGN suggested 
that PI probably participated in astrocyte-neuron communication. 
  
  85 
3.5 Conclusion 
In this chapter, lipidomics analysis was performed in both astrocytes and 
developing neurons. These first-time established lipid profiles with a precise 
molecular lipid signature revealed the differences in phospholipids, 
sphingolipids and sterols metabolisms between these two major types of 
neural cells in the brain, implying that the lipid metabolic pathway is 
preferentially directed into the synthesis of ether lipids and sterol in astrocytes, 
rather than the generation of polyunsaturated phospholipids. The 
consequential plasmalogen elevation, as well as the fatty acyl chain length 
specific alterations of Cer in astrocytes, could be responsible for its highly 
proliferative ability under oxidative stress. On the other hand, the higher ChoL 
abundance in astrocytes serves as an importing resource for neuronal ChoL, 
via a LBPA involved endocytosis. 
Furthermore, lipid changes during the neuronal growth were analyzed for the 
first time. The results implied that SM and ChoL are essential membrane 
materials for axonal and dendritic growth, and may regulate membrane 
polarization as well. Alterations in LBPA, which was possibly derived from 
PG, suggested the involvement of endosomal trafficking during the neuronal 
development. 
  
  86 
4. Lipidomics analysis of subcortical ischemic vascular 
dementia and mixed dementia 
4.1 Introduction 
NSCs and other types of neural cells provide the cellular basis of neural 
development. Aberrant neurogenesis may impair the normal neural 
development and lead to neurodegenerative disease such as dementia. 
Conversely, pathological conditions in dementia could affect neurogenesis as 
well. The close correlation between neurogenesis and dementia suggests that 
the mechanisms regulating neurogenesis could also contribute to the pathology 
of dementia. 
Subcortical ischemic vascular dementia (SIVD) denotes a clinically 
homogenous subtype of vascular dementia (VaD) and represents a leading 
cause of vascular cognitive impairment and dementia, which arises primarily 
from small-artery disease and hypoperfusion [68]. Dementia in SIVD is 
predominantly the result of both complete infarcts (lacunar infarcts and 
microinfarcts) and incomplete infarcts in the deep cerebral white matter, also 
termed white matter lesions (WML) [68]. While SIVD accounts substantially 
for cases of cognitive decline in the elderly, it often remains undiagnosed [68]. 
Given the relatively long prodromal period for dementia, a considerable 
therapeutic window would be available for medical intervention before the 
onset of frank cognitive and behavioral symptoms if accurate diagnosis could 
be made at the preclinical stage [254, 255]. The identification of reliable 
markers that could delineate the early pathogenic events in dementia could 
therefore alleviate the escalating public health burden associated with the 
disease [256]. 
In the recent decade, considerable progress had been achieved in 
understanding the Alzheimer’s disease (AD), both in terms of elucidating 
disease pathogenesis and developing treatment strategies, which is in stark 
contrast to the sporadic information pertaining to VaD [256]. Currently, no 
approved drugs are available for treating VaD, and treatment is usually 
confined to alleviating associated vascular risk factors such as hypertension 
and dyslipidemia [257]. Furthermore, cholinesterase inhibitors and memantine 
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designated for the treatment of AD displayed limited, if any, benefits to VaD 
patients [258]. Thus, there is a pressing need to identify novel therapeutic 
agents effective for VaD treatment. Studies that address the role of brain lipid 
aberrations in VaD pathogenesis have been particularly scarce, especially in 
the recent decade. The idea of perturbed brain lipid homeostasis in VaD had 
been previously investigated by Wallin and colleagues chiefly using thin-layer 
chromatography (TLC). The group reported substantial reductions in 
cerebrosides and sulfatides, and to a smaller extent, cholesterols and 
phospholipids in the white matter of VaD and AD patients, respectively [259]. 
Nonetheless, systematic profiling of the comprehensive brain lipidome of VaD 
patients is still lacking, and therefore requires comprehensive instrumental 
analyses. Indeed, molecular species within the same lipid class could be 
altered to varying extent or even in a reciprocal manner depending on the level 
of unsaturation and/or fatty acyl chain lengths, as it had been previously 
demonstrated in post-mortem AD brain tissues and AD mouse models [81]. 
Thus, the elucidation of a precise molecular lipid signature that defines SIVD 
is prerequisite for deciphering the mechanistic roles of lipids in dementia 
stemming from vascular-related pathologies. The clinically homogenous 
nature of SIVD, as well as its status as the leading cause of vascular-related 
dementia in the elderly [68], renders it a suitable candidate for investigating 
the role of lipids in VaD pathogenesis. 
Mounting evidence indicate the frequent coexistence of brain vascular lesions 
and senile changes in cognitively-impaired individuals [260], and it was found 
that these disorders were often juxtaposed in most population samples [261].  
For instance, in the Honolulu-Asia Aging Study, neuropathological 
examination of demented individuals revealed an appreciable overlap, as well 
as autonomous contributions of AD pathology and vascular infarcts to the 
development of dementia [260]. Indeed, these distinct categories of brain 
pathologies could possibly produce synergistic effects culminating in the 
clinical expression of cognitive impairment and dementia, known as mixed 
dementia (MIX) [256], defined originally as “Alzheimer’s disease and 
cerebral infarcts contributing to the dementia” [262]. Possibly, vascular 
damages could reduce the threshold for clinical manifestation of AD [254, 
263]. Culminating data have shown that the occurrence of pure VaD is rare 
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compared to the mixed phenotype [264]. Moreover, vascular risk factors 
including hypertension, hyperlipidemia, diabetes mellitus and the metabolic 
syndrome predispose individuals to both AD and SIVD [265]. Indeed, 
vasculopathy (and the resultant ischemia) had long been surmised as an 
alternative etiology of AD apart from the broadly-accepted amyloid theory 
[266-268]. In fact, it was also noted cerebrovascular aberrations of the 
endothelial walls, particularly for small vessels in the brains of AD patients, 
which received considerably little attention compared to amyloid-beta (A!) 
aggregates and neurofibrillary tangles that now constitute the hallmark 
features of AD [266]. The co-occurrence of disease phenotypes implies that 
vascular defects and neurodegenerative changes may interact on several levels. 
Elucidating the molecular details of such interactions, as well as the respective 
contributions of vascular and Alzheimer’s pathology to cognitive deficits in 
MIX might therefore help identify the primary pathogenic mechanism in AD 
per se. 
In this chapter, we report the comprehensive lipidomics profiling of the white 
matter and grey matter from the temporal cortex of patients with SIVD and 
MIX, respectively, and in comparison to age-matched, non-demented controls 
using high-performance liquid-chromatography coupled to mass spectrometry 
(HPLC/MS) as the principal analytical platform. To our knowledge, this is the 
very first lipidomic study that systematically characterizes the distinct brain 
lipid molecular signatures of SIVD and MIX patients. This study identifies 
novel molecular therapeutic targets for SIVD and confers new insights 
pertaining to the interactions between vascular and neurodegenerative lipid 
pathology in contributing to dementia.  Moreover, the correlation with lipid 
profiles obtained from in vitro cell culture systems might help understand the 
pathology of dementia at the cellular level. 
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4.2 Materials and methods 
4.2.1 Subjects and tissue processing 
The management of the cases was kindly done by Michelle Widdrington, 
Carein Todd, Jean Scott, Deborah Lett and Anne Nicholson. In Singapore, this 
study is supported by a Clinician Scientist Award to Christopher Chen as well 
as a Centre grant to Mitchell Lai and Christopher Chen from the National 
Medical Research Council of Singapore. In the UK, this study is supported by 
grants to Newcastle Centre for Brain Ageing and Vitality (BBSRC, EPSRC, 
ESRC and MRC, LLHW), and Alzheimer’s Research (ARUK). Tissues were 
collected by the Newcastle Brain Tissue Resource, which is funded in part by 
a grant from the UK MRC, by the Newcastle NIHR Biomedical Research 
Centre in Ageing and Age Related Diseases award to the Newcastle upon 
Tyne Hospitals NHS Foundation Trust, and by a grant from the Alzheimer’s 
Society and ARUK as part of the Brains for Dementia Research (BDR) 
Project. 
Post-mortem frozen brain tissues from SIVD, MIX and age-matched normal 
control subjects (Table 4-1 and Supplementary Table S4-1) were obtained 
from the Newcastle Brain Tissue Resource, Institute for Ageing and Health, 
Newcastle University. Informed consent was obtained from the guardians of 
the patients prior to donation of  brain tissues, and approval was granted by 
local research ethics committees (National University Health System, 
Singapore and Newcastle upon Tyne Hospitals Trust, UK). For this study, we 
assessed samples of both grey and white matter from the temporal lobe 
(Brodmann area 21). We focused on the temporal lobe because medial 
temporal lobe atrophy is a common finding in dementia and  recent study 
suggested a vascular basis for neurodegeneration [269].  The temporal lobe is 
also relatively free of large infarcts [270].  Final classification of subjects was 
assigned based on established neuropathological diagnostic criteria. Briefly, 
haematoxylin-eosin staining was used for assessment of structural integrity 
and infarcts, Nissl and Luxol fast blue staining for cellular pattern and myelin 
loss, Bielschowsky’s silver impregnation for ‘Consortium to Establish a 
Registry for Alzheimer's Disease (CERAD)’ rating of neuritic plaques and tau 
immunohistochemistry for ‘Braak’ staging of neurofibrillary tangles [271]. A 
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diagnosis of SIVD was made when there were multiple or cystic infarcts, 
lacunae, microinfarcts and small vessel disease, and Braak stage < III [270]. 
The diagnosis of MIX was assigned when there was evidence of significant 
Alzheimer’s type pathology namely Braak stage V-VI and moderate-severe 
vascular pathology. Vascular pathology was graded according to the scoring 
system described previously [272].  Control subjects had no clinical evidence 
of dementia, neurological or physchiatric disease.  Furthermore, tissue 
samples from controls were determined not to have sufficient pathology to 
reach threshold to ascertain a diagnosis for dementia. 
Table 4-1. Demographic and disease variables in a cohort of control and 
dementia patients. 
 Control SIVD MIX 
N 14 11 10 
Age at Death (years) 79.9 ± 2 85.3 ± 3 83.4 ± 3 
Sex (Male/Female) 6M / 8F 7M / 4F 5M / 5F 
Postmortem Interval (hours) 35.4 ± 5 44.8 ± 12 43.7 ± 9 
Data are mean ± S.E.M. MIX, mixed dementia (SIVD / Alzheimer’s disease); N, number of 
cases; SIVD, subcortical ischemic vascular dementia. 
 
4.2.2 Lipid extraction 
Lipid extraction was done together with Sin Man Lam. Frozen tissues were 
inactivated with 900!L of chloroform:methanol (1:2) containing 10% 
deionized H2O . Tissue samples were cut into fine pieces using micro-scissors 
on dry ice, and methanol was used to thoroughly wash the micro-scissors 
between samples. Samples were homogenized and incubated at 1, 200rpm, 
4°C, for 1 hour in a thermomixer. At the end of the incubation, 400!L of 
deionized H2O and 300!L of chloroform were added and vortexed. Samples 
were then centrifuged at 12, 000 rpm, 4°C, for 5 minutes.  Lower organic 
phase was extracted. Second extraction was carried out by adding 50!L of 1M 
hydrochloric acid and 500!L of chloroform. Extracted organic fractions were 
pooled and dried using speed-valco (Thermo Savant, Milford, USA). Samples 
were stored at -80°C until further analysis. 
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4.2.3 Lipid analysis 
Polar lipids analysis were analyzed on an Agilent 1200 HPLC system coupled 
with an Applied Biosystem Triple Quadrupole/Ion Trap mass spectrometers 
3200 Qtrap as described previously [173]. Individual lipid species were 
quantified using spiked internal standards including PC, 14:0/14:0; PE, 
14:0/14:0; PS, 14:0/14:0; PG, 14:0/14:0; C12-SM, C17-Cer, C12-SL, C8-
GluCer, as well as C17-GM3, which were all obtained from Avanti Polar 
Lipids (Alabaster, AL, USA). Dioctanoyl phosphatidylinositol (PI, 16:0-PI) 
was used for lysophosphatidylinositol quantitation and obtained from Echelon 
Biosciences, Inc. (Salt Lake City, UT, USA). LBPA was normalized to PG 
internal standard and GalCer was normalized to GluCer internal standard 
[173]. Glycerol lipids TAG and DAG were analyzed using a modified 
protocol of reverse-phase HPLC/ESI/MS described previously [273]. 
Separation of lipids aforementioned was carried out on a Phenomenex Kinetex 
2.6µ-C18 column (i.d. 4.6 ! 100 mm) using an isocratic mobile phase 
chloroform:methanol:0.1M ammonium acetate (100:100:4) at a flow rate of 
150 µL/min for 17 min. Amount of TAG was calculated relative to the spiked 
d5-TAG 48:0 internal standard (CDN isotopes), while DAG species were 
quantified using 4ME 16:0 Diether DG as an internal standard (Avanti Polar 
Lipids, Alabaster, AL, USA). Free cholesterol and cholesterol esters were 
analyzed as described previously with corresponding d6-cholesterol and d6-
C18 cholesterol ester (CDN isotopes) as internal standards [174]. 
 
4.2.4 Data processing 
Statistical analysis was done with the help of Xinrui Duan. Molar fractions of 
individual lipid classes and species were used for statistical analyses. One-way 
ANOVA with post-hoc Tukey’s test was performed to compare the changes in 
lipid profiles between control, SIVD and MIX. The correction of multiple 
comparisons was done by controlling the false discovery rate using the q value 
(R 3.0.1). For all bar graphs, error bars represent standard errors of the mean. 
For all cases, #p<0.10; * p < 0.05; ** p < 0.01; *** p < 0.001. 
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4.3 Results 
A total of 334 distinct lipid species from 17 lipid subclasses including neutral 
lipids such as cholesteryl esters (CE), cholesterols (ChoL), diacyglycerides 
(DAG), triacylglycerides (TAG); sphingolipids including ceramides (Cer), 
galactosylceramides (GalCer), glucosylceramides (GluCer), sphingomyelins 
(SM), ganglioside mannoside 3 (GM3) and sulfatides (SL); as well as 
phospholipid subclasses of phosphatidylcholines (PC), 
phosphatidylethanolamines (PE), phosphatidylglycerols (PG), 
phosphatidylinositols (PI), phosphatidylserines (PS), phosphatidic acids (PA) 
and lysobisphosphatidic acids (LBPA) were analysed. The purity of the white 
and grey matter obtained in this study was verified based on their respective 
molecular compositions of plasmalogen phosphatidylethanolamine species 
(pPE) (Supplementary Figure S4-1). It has been reported that the predominant 
presence of pPE containing polyunsaturated fatty acids (PUFA) in the grey 
matter, with the unsaturated fatty acyls probably constituting essential 
components of signal transduction pathways. On the other hand, pPE in the 
white matter were found to be comparatively less unsaturated in nature [274]. 
Accordingly, the grey matter was observed to contain a significantly higher 
level (p<0.001) of polyunsaturated pPE (n>4) than the white matter in the 
current study (Supplementary Figure S4-1). 
Interestingly, alterations in lipid profiles for SIVD patients were concentrated 
in the white matter (Supplementary Figure S4-2), while that for MIX (i.e. 
AD+VaD) were mainly localized to the grey matter (Supplementary Figure 
S4-3). These observations were aligned with the neuropathophysiology of the 
respective diseases, since SIVD is largely characterized by vascular lesions of 
the cerebral white matter [68, 275], while AD essentially entails a dysfunction 
of chemical synapses coupled with degeneration of the hippocampal neurons 
[276-278], both of which are mainly found in the grey matter of the brain 
tissues. 
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Figure 4-1. Changes of lipids at the subclass level amongst control (n=14), SIVD (n=11) 
and MIX (n=10) for (A) white matter and (B) grey matter. Lipid classes were expressed as 
mean molar fractions with error bars indicating mean + S.E.M. Statistical significance was 
determined using one-way ANOVA with post-hoc Tukey test, and the correction of multiple 
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4.3.1 Overall reductions in sphingolipids in SIVD white matter 
 
Figure 4-2. Comparative lipid profiles of sphingolipids in the white matter of control 
(n=14), SIVD (n=11) and MIX (n=10). (A) Cer; (B) SM; (C) GluCer; (D) GM3; (E) GalCer 
and (F) SL. Lipid species were expressed as mean molar fractions with error bars indicating 
mean + S.E.M. Statistical significance was determined using one-way ANOVA with post-hoc 
Tukey test, and the correction of multiple comparisons was done by controlling the false 
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Significant reductions in the classes of GalCer and SL (p<0.05) were observed 
in SIVD white matter, in corroboration with the reported decreases in 
cerebrosides and SL in VaD [259]. In addition, Cer and GluCer also decreased 
albeit not reaching statistical significance, while total SM were increased. 
Also in agreement with a previous study based on TLC [259], total GM3 
amount was not significantly altered (Figure 4-1. A). Molecular profiles of the 
sphingolipidome showed that Cer species comprising short-chain fatty acyls 
(C16-C18) were elevated, while the amounts of very long chain (VLC)-Cer 
(24C) were specifically reduced (p<0.05) (Figure 4-2. A). Parellel increases in 
short-chain SM with the corresponding fatty acyl chain lengths (Figure 4-2.B) 
were observed, accompanied by diminished amounts of C18-GluCer (Figure 
4-2. C). Notably, GM3 18:1/16:1 exhibited ~25% increase in SIVD compared 
to control (p<0.05) (Figure 4-2. D). On the other hand, individual species of 
GalCer and SL were all consistently reduced in SIVD white matter (Figure 4-2. 
E and F). The specific increases in short-chain Cer and SM in SIVD white 
matter suggested that excess short-chain Cer were probably channelled into 
SM, resulting in diminished amounts of other downstream glycosphingolipids 
including GluCer, GalCer and SL with the corresponding fatty acyl moieties. 
On the other hand, the overall reductions in glycosphingolipids containing 
VLC-fatty acyls might have resulted from the attenuated biosynthesis of 
upstream VLC-Cer. 
 
4.3.2 Changes in phospholipids in SIVD white matter  
Contrary to the overall reductions in the white matter sphingolipidome, 
appreciable increases were observed in numerous phospholipid classes 
including PC, PS and PG (Figure 4-1. B). Notably, individual species of PC, 
PS and PG were also predominantly elevated in SIVD with statistical 
significance (Figure 4-3. A-C).  The trend was remarkably striking for PG 
with ~1.5 fold increase, for which all individual species were also consistently 
increased (Figure 4-3. B). Also notable is that the amounts of several 
polyunsaturated PS, such as PS 36:3, PS 36:4, PS 38:4, PS 40:7, PS 40:5 and 
PS 40:4, were specifically augmented in SIVD (p<0.05) (Figure 4-3. C). 
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While total PE did not change appreciably (Figure 4-1. A), molecular 
compositions of pPE seemed to be altered according to their levels of 
unsaturation.  Notably, PE 36:2p, 36:3e, the most abundant species in non-
demented controls, were reduced substantially in SIVD while PE 40:6p, 40:7e 
was increased with marginal significance (p<0.10) (Figure 4-3. D). On another 
note, most diacyl-PE species were increased in SIVD (Figure 4-3. E). 
 
4.3.3 Other notable lipid perturbations in SIVD 
An appreciable accumulation of total CE, accompanied by a concomitant 
decrease in free ChoL, was noted in SIVD white matter (p<0.10) (Figure 4-1. 
A). Molecular profiles revealed that CE 16:0, CE 18:2 and CE 18:1 were 
appreciably increased (p<0.05) in SIVD (Supplementary Figure S4-2). 
Notably, total PI in SIVD grey matter were significantly reduced (p<0.05) 
(Figure 4-1. B). In addition, significant decreases in individual PI species 
containing three or more double bonds in their structures were also 
consistently observed in the grey matter (Supplementary Figure S4-3). 
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Figure 4-3. Comparative lipid profiles of phospholipidsin the white matter of control 
(n=14), SIVD (n=11) and MIX (n=10). Heatmaps illustrate the fold change in individual 
phospholipid species in the white matter of SIVD and MIX compared against control from the 
subclasses of (A) PC; (B) PG and (C) PS. Barplots indicate molar fractions of individual 
species of (D) plasmalogen PE and (E) diacyl-PE in the white matter of control, SIVD and 
MIX. Lipid species were expressed as mean molar fractions with error bars indicating mean + 
S.E.M. Statistical significance was determined using one-way ANOVA with post-hoc Tukey 
test, and the correction of multiple comparisons was done by controlling the false discovery 
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4.3.4 Enhanced sphingolipids in MIX grey matter 
The amounts of various sphingolipid classes were predominantly increased in 
MIX grey matter (Figure 4-4). With the exception of SM and GM3, which 
exhibited changes dependent on fatty acyl heterogeneity (see below), total Cer 
(p<0.10), GluCer (p<0.10), GalCer (p<0.10), and SL (p<0.05) were all 
increased in MIX grey matter (Figure 4-1. B). Detailed molecular profiles 
indicated that VLC-Cer (C22-C24) were significantly enriched (Fig. 4-4A), 
with parallel increases in VLC-SM containing the corresponding fatty acyls 
(Figure 4-4. B). In contrast, SM species comprising shorter fatty acid residues 
(C18-C20) were significantly reduced in MIX grey matter (Figure 4-4. B). The 
reciprocal changes in SM based on fatty acyl chain lengths were in agreement 
with previous observations in post-mortem prefrontal cortex, but surprisingly 
opposite to that in the entorhinal cortex, of AD human brains [81]. While 
individual species of GluCer were all consistently increased (Figure 4-4. C), 
short-chain GM3 (C16-C20) were reduced compared to control, albeit not 
reaching statistical significance (Figure  4-4. D). On the other hand, VLC-
GM3 displayed remarkable increases in MIX, with ~2 fold increase observed 
for GM3 18:1/24:1 and GM3 18:1/24:0 (p<0.05) (Figure 4-4. D), which 
coincides with the reported selective enrichment of VLC-GM3 in the human 
AD entorhinal cortex [81]. In addition, all individual species of GalCer and SL 
were consistently increased in MIX grey matter compared to controls (Figure 
4-4. E and F). The elevated SL amount in MIX contradicted previous studies 
that reported lower SL amount in the grey (and white) matter of early AD 
[279], as well as reduced (albeit not statistically significant) amount of SL in 
the prefrontal and entorhinal cortices of post-mortem AD brain tissues [81]. 
Nonetheless, a significant increase in SL was reported in aged apolipoprotein 
E (APOE)-!4 knock-in mice compared to their !3 counterparts under high-fat-
high-cholesterol diet [280]. In addition, individual SL species were 
predominantly increased with aging regardless of both diet and APOE 
genotype [280], which seems to suggest an alternative role of SL in AD 
pathogenesis. 
Therefore, a discernible metabolic shift towards elevated amounts of 
glycosphingolipids, instead of SM, was noted in MIX. In addition, as the 
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amounts of relatively short-chain Cer (C16-C20) were only modestly 
increased in MIX, degradation of SM with the corresponding fatty acyls might 
have occurred to generate additional Cer that would serve as precursors for the 
biosynthesis of short-chain glycosphingolipids further downstream. Notably, 
long-chain SL (C22-C24) exhibited progressive increases from control to 
SIVD to MIX (Figure 4-4. F), suggesting that the interaction between vascular 
and neurodegenerative pathology in MIX might have additive effects on this 
specific class of lipids in the grey matter. 
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Figure 4-4. Comparative lipid profiles of sphingolipids in the grey matter of control 
(n=14), SIVD (n=11) and MIX (n=10). (A) Cer; (B) SM; (C) GluCer; (D) GM3; (E) GalCer 
and (F) SL. Lipid species were expressed as mean molar fractions with error bars indicating 
mean + S.E.M. Statistical significance was determined using one-way ANOVA with post-hoc 
Tukey test, and the correction of multiple comparisons was done by controlling the false 
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4.3.5 Alterations in phospholipids in MIX grey matter 
Major phospholipid classes of PC (p<0.10) and PE (p<0.10), as well as total 
PG (p<0.05) were reduced in MIX compared to controls (Figure 4-1. B). In 
addition, total LPC (inclusive of LPCe) were decreased (p<0.05) (Figure 4-1. 
B). Molecular profiling indicated while that diacyl-PC were predominantly 
reduced, several plasmalogen-PC (pPC) species including PC34:1p, PC34:0p, 
PC36:3p, PC 36:2p, PC 36:1p and PC 38:4p were significantly enriched 
(p<0.05) in MIX (Figure 4-5. A). In addition, in agreement with Chan et al 
[81], all individual PG (Figure 4-5. B) and LPC (including LPCe) species 
(Figure 4-5. C) were consistently decreased. On another note, numerous PA 
species such as PA 32:1, PA 36:2 and PA 36:1 were significantly elevated 
(p<0.05) (Figure 4-5. D). Notably, total LBPA were enriched by ~1.8 fold in 
MIX compared to control (Figure 4-1. B), which is in close agreement with a 
reported ~1.8 fold increase in LBPA in the entorhinal cortex of AD human 
brains [81]. Individual LBPA species also exhibited remarkably consistent 
increases in MIX grey matter (Figure 4-5. E). Moreover, total LBPA exhibited 
progressive increases from control to SIVD to MIX (Figure 4-1. B). Contrary 
to a previous report [274], but in accordance with Chan et al [81], no 
significant changes in total pPE were observed in MIX (Supplementary Figure 
S4-4. A and B). Nonetheless, polyunsaturated pPE such as PE40:6p, 40:7e 
was significantly reduced (p<0.05), while less unsaturated pPE including 
PE34:1p, 34:2e and PE36:2p, 36:3e were increased (p<0.05) (Figure 4-5. F). 
Indeed, an overall reduction in polyunsaturated pPE (n >4) was observed in 
MIX grey matter, accompanied by concomitant increases in pPE containing 
only one (p<0.05), two (p<0.01) or three (p<0.05) double bonds in their 
structures (Supplementary Figure S4-4. D). On the other hand, total diacyl-PE 
(p<0.10) (Figure 4-1. B), as well as several individual diacyl-PE species, were 
significantly reduced in MIX (Figure 4-5. G). 
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Figure 4-5. Comparative lipid profiles of phospholipids in the grey matter of control 
(n=14), SIVD (n=11) and MIX (n=10). Heatmaps illustrate the fold change in individual 
phospholipid species in the grey matter of SIVD and MIX compared against control from the 
subclasses of (A) PC; (B) PG; (C) LPC; (D) PA and (E) LBPA. Barplots indicate molar 
fractions of individual species of (F) plasmalogen PE and (G) diacyl-PE in the grey matter of 
control, SIVD and MIX. Lipid species were expressed as mean molar fractions with error bars 
indicating mean + S.E.M. Statistical significance was determined using one-way ANOVA 
with post-hoc Tukey test, and the correction of multiple comparisons was done by controlling 








































































































































































































































































































































































































































































































































































Supplementary Fig. S4. 
Comparison of the levels of total plasmalogen PE and diacyl-PE in the (A) white matter and (B) 
grey matter of control, SIVD and MIX. Comparison of the changes in the degree of unsaturation of 
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4.4 Discussion 
While SIVD mainly affects the subcortical regions of the brain parenchyma, 
the choice of the cortex for lipidomics analysis could potentially yield lipid 
changes that are etiologically linked to the subcortex on a circuit-wide basis, 
such as those affecting neurotransmission. Therefore, the observed lipid 
derangements in the cortex, instead of the damaged tissues in the subcortex, 
possibly reflect primary pathogenic events associated with the early stage of 
the disease.  In addition, the cortex tissues are less susceptible to post-mortem 
damage, and could therefore better indicate changes of a neuropathological 
origin [281]. 
 
4.4.1 Sphingolipid aberrations in SIVD indicated disruptions to 
myelin structural integrity 
Since cerebrosides are largely confined to myelin, the considerable reductions 
in GluCer, GalCer and SL in SIVD white matter suggested that the myelin 
sheath represents a primary site of these changes, which is consistent with the 
previous observations of extensive myelin destruction with relatively minor 
neuronal damages in VaD [259]. Moreover, deficiency in GalCer and SL, 
which are almost exclusively synthesized by oligodendrocytes, had shown to 
lead to axonal dysfunction, dysmyelinosis and loss of axonal conduction 
velocity in mice models [282, 283]. Indeed, it had been shown that 
oligodendrocytes swelling and myelin sheath aberrations occurred prior to 
(and independently of) neuronal damage in the event of ischemia [284]. It is 
thus probable that under hypoperfusion in SIVD, available oxygen is 
preferentially channelled to preserve the functionally important neurons, 
leading to selective death of oligodendrocytes that also have considerably high 
metabolic demands [259]. This would also account for the predominant 
localization of vascular lesions to the white matter, rather than the grey matter, 
of the temporal cortex observed in the current study. 
Surprisingly, the sphingolipid and neutral lipid derangements observed in 
SIVD white matter closely resembled the brain lipid profiles of ceramides 
synthase 2 (CerS2)-null mice previously reported in an independent study 
[285]. CerS2 represents a member of the family of six enzymes that catalyses 
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the de novo synthesis of Cer via N-acylation of a sphingoid base. In particular, 
CerS2 preferentially utilizes VLC acyl-CoAs (C22-C24) for the biosynthesis 
of VLC-Cer [286]. In CerS2-null mice, reductions in C22-C24-Cer and C22-
C24-SM were observed, accompanied by concomitant increases in C18-Cer 
and C18-SM and an overall reduction in GalCer. In addition, a marginal 
increase in CE was reported [286]. Notably, CerS2-null mice exhibited myelin 
degeneration and detachment from axons without appreciable neuronal loss, 
coupled with motor dysfunction characterized by fast myoclonic jerks and loss 
of posture, which were indicated to be of a subcortical origin from 
electroencephalogram recordings [286]. Indeed, white matter lesions and 
psychomotor disturbances also represent the major neuropathological and 
clinical manifestations of SIVD [275]. 
 
4.4.2 Enhanced phospholipid unsaturation in SIVD as an adaptive 
response to chronic ischemia 
The increase in phospholipid content in SIVD white matter contrasted with 
earlier studies reporting phospholipid catabolism under transient cerebral 
ischemia, which could be attributed to (1) lipid peroxidation and/or (2) 
activation of hydrolytic enzymes [287]. Nonetheless, a separate study argued 
against phospholipid membrane disintegration, but pointed instead to an 
augmented level of polyunsaturated fatty acids, during ischemia [288]. The 
paradoxical increase in polyunsaturated pPE and PS under chronic 
hypoperfusion in SIVD might be associated with the location of white matter 
tissues chosen for analysis. Previous analysis had reported the predominant 
localization of parenchymal lesions in the frontal and parietal lobes, instead of 
the temporal lobe, in the brains of SIVD patients [289].  Thus, the small 
vessels in the temporal lobe might be less severely affected in SIVD, or only 
afflicted at advanced stages. Therefore, the observed enhancement in 
phospholipid unsaturation in the temporal cortex might be associated with 
“remote ischemic preconditioning” [290], in which prolonged ischemia 
experienced in the frontal and parietal lobes might possibly trigger adaptive 
mechanisms (e.g. increase unsaturation) in the temporal cortex for protection 
against impending oxidative insults. Notably, ischemic preconditioning had 
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been reported to enhance antioxidants in the brain and peripheral organs 
following cerebral ischemia [291]. 
 
4.4.3 Polar lipid changes in MIX consistent with endolysosomal 
dysfunction and increased oxidative stress characteristic of AD 
molecular pathology 
The global accumulation of sphingolipids is in line with the endolysosomal 
dysfunction theory for AD pathogenesis [292].  Indeed, the drastic 
accumulation of the unconventional phospholipid, LBPA, also confers support 
for this theory, since LBPA is localized exclusively within the internal 
membranes of late endosomes, and had been implicated in specifically sorting 
lipids either for lysosomal degradation or plasma membrane recycling [212]. 
A notable finding in this study is the reciprocal changes in SM and GM3 
depending on fatty acyl heterogeneity in the MIX grey matter, which might be 
attributed to the critical roles of fatty acid chain lengths in mediating 
endocytic trafficking and lipid raft functions. Specifically, cholesterol loading 
was shown to elevate intracellular accumulation of long-chain SM via 
enhanced targeting of these species for recycling back to the plasma 
membrane, instead of degradation in lysosomes [293], consistent with the 
observed increases in free ChoL and VLC-SM in this study (Supplementary 
Figure S4-4. B). This demonstrated that acyl chain length affects endocytic 
routing of lipids. Furthermore, SM and gangliosides constitute important 
components of lipid rafts in neuronal membranes [294] that serve critical 
functions in providing docking sites for receptors and catalytic enzymes 
pivotal to AD pathogenesis [294, 295]. The acyl chain components of raft 
lipids could therefore exert varying yet determining effects on the stability of 
individual membrane rafts, which may have far-reaching effects on cellular 
signalling and biochemistry. Indeed, similar opposing trends in GM3 based on 
fatty acid chain lengths had been observed in the plasma of type 2 diabetes 
patients, and GM3 fatty acyl heterogeneity was proposed to influence lipid raft 
formation critical for mediating insulin receptor signalling [296]. In addition, 
compared to short-chain GM3, the augmented amounts of VLC-GM3 in grey 
matter might be even more detrimental to AD pathogenesis [297], as the 
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longer fatty acyl chains are expected to confer stronger hydrophobic forces in 
overcoming the electrostatic repulsion between sialic acid residues to form 
ganglioside-enriched membrane clusters, previously shown to be involved in 
seeding A! polymerization [296-298]. 
The overall reduction in major membrane phospholipids including PC and PE 
in MIX also coincided with previous observations in AD, which attributed the 
decrease to membrane defects associated with neurodegenerative events [299, 
300]. In particular, A! oligomers had been shown to disrupt membrane 
integrity via currently unknown mechanisms [301]. In addition, the overall 
reduction in diacyl-PC, as well as increases in corresponding diacyl-PA and 
DAG species largely comprising saturated/monounsaturated fatty acids 
indicated enhanced phospholipase D (PLD) activity in MIX [302]. Indeed, 
PLD-2 ablation had been previously shown to rescue AD-linked synaptic 
dysfunction and cognitive deficits in AD mouse model [303]. 
 
4.4.4 Contribution of vasculopathology and neuropathology to 
mixed dementia 
While lipid changes in MIX grey matter were predominantly in accordance 
with AD pathology, the progressive increase in SL from control to SIVD to 
MIX contradicted with the previously reported SL reduction in early AD [279], 
and in the prefrontal and entorhinal cortices of post-mortem AD human brains 
[81]. The increase in grey matter SL in MIX might thus be attributed to the 
additive effects of concurrent vascular lesions in addition to neurodegenerative 
changes. Under normal physiological condition, SL-containing APOE-
associated lipoproteins are either taken up by neurons and metabolized via the 
endolysosomal pathway, or transported to the peripheral circulation and 
removed from the brain tissues via the cerebrospinal fluid (CSF) [304]. A 
general state of hypoperfusion in brain parenchyma in SIVD and MIX could 
possibly impede the clearance of SL-containing lipoproteins via the CSF, 
which might be further exacerbated in MIX due to the compromised 
endolysosomal pathway in neurons, leading to SL accumulation within grey 
matter. Indeed, endolysosomal dysfunction might have commenced in early 
SIVD, as evident in the progressive accumulation of LBPA in grey matter 
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from SIVD to MIX, but the effect might have been masked in SIVD due to 
attenuated glycosphingolipid synthesis as discussed above. 
Neuronal SL over-accumulation per se, without demyelination, had been 
reported to cause axonal degeneration in a mouse model of metachromatic 
leukodystrophy [305]. In addition, SL were shown to trigger inflammatory 
responses in the brain immune system in a manner partly dependent on L-
selectins, which are receptor proteins located on activated vascular endothelial 
cells, leukocytes and activated platelets [306]. While current lipidomics data 
seemed to suggest that MIX phenotype could be, to a greater extent, attributed 
to neuropathological aberrations instead of vasculopathology, it is nonetheless 
crucial to reckon that SIVD and AD might alter the brain parenchyma in a 
region-specific manner. As parenchymal lesions in SIVD were predominantly 
located in the frontal and parietal lobes, instead of the temporal lobe [289], the 
choice of the temporal cortex for analysis could possibly have biased the MIX 
lipidome towards a greater manifestation of neurodegenerative phenotype 
resembling AD. !  
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4.5 Conclusion 
In this chapter, we have established a reference frame of lipids that could be 
targeted for advancing current diagnostic and therapeutic endeavors in the 
context of SIVD and MIX. In particular, based on the close resemblance in 
brain sphingolipid profiles of CerS2-null mice [285] with the anomalies in 
SIVD sphingolipidome reported herein, we surmise that CerS2 could be a 
candidate enzyme implicated in SIVD pathogenesis that warrants further 
investigation. Indeed, the mechanisms that connect small vessel disease with 
brain parenchymal lesions have remained discordant and elusive, primarily 
due to a lack of appropriate animal models that can convincingly reflect the 
pathological aberrations observed in humans [307]. Our lipidomics data thus 
suggest that CerS2-null mice could be a potentially relevant model for human 
SIVD. In addition, this study underscored the critical importance of 
sphingolipid fatty acyl chain heterogeneity in neuropathology, and identified 
SL accumulation in the grey matter of temporal cortex, which could likely be 
attributed to the synergistic interactions between vascular and 
neuropathological lesions co-occurring specifically in MIX, as a possible 
marker that could distinguish pure AD from MIX. 
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5. Final Discussion 
5.1 Redox state and oxidative stress in neural development 
The redox state is a key factor regulating the switch between self-renewal and 
differentiation in NSCs. Combined with previous genomics and proteomics 
data that indicate the expression of relevant enzymes in lipid metabolisms, a 
differentially regulated lipid network was proposed in NSCs for the first time 
compared with fate-committed progenitors and differentiated cells (Chapter 2). 
This proposed lipid network reveals an upregulation in phospholipids 
accompanied by the decrease in sphingolipids and sterols. The dominantly 
elevated phospholipids implied an upregulation of unsaturated 
phphospholipids in NSCs, which had been supported by the enhanced 
expression and higher activity of fatty acid synthase (Fasn) [186]. In addition, 
the oxidation of FA is most likely to be downregulated in NSCs, followed by a 
reduced oxidation of downstream ChoL. Hence the cellular environment in 
NSCs is less oxidative than progenitors and differentiated cells, which 
maintains stem cells in an undifferentiated state. The oxidative environment 
also plays an important role in differentiated neural cells (Chapter 3). The 
reduced polyunsaturated PC/PE and the appreciable elevation in ChoL are in 
line with previous genomics studies showing that FA degradation is enhanced 
in NSCs followed by an upregulated ChoL synthesis. Plasmalogens are 
believed to be antioxidant in cells as the vinyl double bonds are preferentially 
attacked by oxidants than the double bond found in polyunsaturated fatty acid, 
so that phospholipid and ChoL can be protected from oxidative injury [237]. 
Thus, the accumulation of plasmalogen lipids in astrocytes is probably related 
to its antioxidative ability under oxidative stress caused by traumatic injury or 
pathological conditions. The decreased polyunsaturated PC and PE implies a 
downregulated unsaturation degree, which might lead to a more oxidative state 
in astrocytes compared with neurons, and makes astrocytes less likely to be 
affected by oxidants. Moreover, the lipid profile from dementia patients brain 
tissues further indicates that the influence of oxidative stress is crucial during 
neural development (Chapter 4). The upregulation of phospholipid 
unsaturation in the less affected temporal cortex in SIVD might be associated 
with “remote ischemic preconditioning”, in which prolonged ischemia 
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experienced in the frontal and parietal lobes might possibly trigger adaptive 
mechanisms (e.g. increase unsaturation) in the temporal cortex for protection 
against impending oxidative insults. This ischemic preconditioning probably 
enlarges the reserved antioxidants pool in the brain and peripheral organs 
following cerebral ischemia, so as to attenuate the massive oxidative stress 
[291]. On the other hand, the downregulated diacyl-PC, PE and PG in MIX 
grey matter implied a more oxidized cellular environment in these brain 
regions. The reduction in polyunsaturated plasmalogen PE and 
polyunsaturated PS in the MIX grey matter were consistent with an elevated 
degree of ischemia and oxidative stress expected in the MIX phenotype. 
As one of the classic neurogenesis areas in the brain, hippocampus is located 
near the temporal lobe. The increased unsaturation of lipids in SIVD white 
matter in the temporal cortex is in line with alterations in NSCs observed in 
vitro, whereas similar aberrations are not found in MIX. These results allow us 
to correlate the discrepancy in lipids alterations with the distinct response of 
neurogenesis in MIX and SIVD respectively. It has been shown that 
neurogenesis is most likely to be enhanced in VaD yet it is compromised in 
AD as introduced in Chapter 1. Evidence showed that precursor cells can be 
observed in both peri-infarct and neurogenesis area in VaD patients brain. 
Those multipotent cells probably migrate from neurogenesis niche to the peri-
infarct areas and further differentiate into neurons [65]. Hence it might be able 
to hypothesize that the differentially regulated redox state in SIVD suggests 
the generation of  neural precursors, yet it is not clear the exact location of 
neurogenesis. However,  neurogenesis in MIX is possibly attenuated and 
aligned  with the phenomenon in AD patients. 
Taken together, degree of unsaturation, plasmalogen lipids and lipids 
oxidation are the key factors controlling the redox state, and further regulate 
the cellular functions during neural development. Moreover, the redox state 
indicated by lipid profiles from the in vitro cell culture and brain tissues of 
dementia patients might suggest the increase of neural precursors in SIVD, 
affirming the correlation between neurogenesis and dementia. 
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5.2 Lipids alterations implicating the importance of membrane 
integrity in neural development 
PC, SM and ChoL are known as the three major components in plasma 
membranes. Significant differences in the relative abundance of these lipids 
are observed in NSCs compared to progenitors and differentiated cells 
(Chapter 2). Diacyl-PC was elevated during the NSC-enrichment in 
neurospheres, accompanied by a downregulation of ChoL. This reciprocal 
alteration in diacyl-PC and ChoL was also found in 24S-OH treated NSC-
enriched neurospheres, showing that diacyl-PC was elevated yet ChoL was 
dowregulated, and further resulted in an attenuation of following neurogenesis. 
These observations suggested that the metabolism of PC might be closely 
interacted with sterols. The alterations of lipid composition in membranes may 
influence the structure and function of lipid rafts, and further regulate the 
switch between self-renewal and differentiation in NSCs. The relative 
abundance of these membrane lipids are also differentially regulated in 
differentiated neural cells (Chapter 3). Astrocytes exhibited a reduction of 
diacyl-PC in accord with the significant upregulation of ChoL and SM 
compared with neurons. The accumulation of ChoL and SM at particular 
stages during neuronal development implied that these two membrane lipids 
are playing critical roles in membrane constitution and polarization of 
neuronal growth, and are likely to be co-regulated within certain 
developmental stages. On the other hand, diacyl-PC was downregulated, 
which might accommodate the membrane integrity. Lipidomics analysis in 
SIVD and MIX affirms the functions of lipids in membrane integrity (Chapter 
4). In the grey matter of MIX patients, the upregulated ChoL amount is in line 
with the pathology of AD as altered ChoL accompanied by polyunsaturated 
fatty acyl containing phospholipid may influence membrane fluidity and 
further regulate the activity of relevant enzymes that are responsible for the 
production of A! [145, 147]. Moreover, SM and gangliosides constitute 
important components of lipid rafts in neuronal membranes [294] that serve 
critical functions in providing docking sites for receptors and catalytic 
enzymes pivotal to AD pathogenesis [294, 295]. The reciprocal chain-length 
specific alterations in SM and GM3 implied the critical roles of fatty acid 
  112 
chain lengths in mediating endocytic trafficking and lipid raft functions. The 
acyl chain components of raft lipids could therefore exert varying yet 
determining effects on the stability of individual membrane rafts, which may 
have far-reaching effects on cellular signalling and biochemistry. Besides, the 
overall reduction in major membrane phospholipids including PC and PE in 
MIX also coincided with previous observations in AD, which attributed the 
decrease to membrane defects associated with neurodegenerative events [299, 
300]. 
Notably, the abundance of diacyl-PC and ChoL are often reciprocally 
regulated. The property of stemness in NSCs seems to be maintained with the 
elevation of PC and compromised during the neuronal growth when PC is 
reduced. Given the hypothesis that neurogenesis is enhanced in the SIVD but 
MIX patients brain, the accumulation of PC together with the decreased ChoL 
in SIVD agrees well with its effect in maintaining the multipotency  of NSCs, 
while PC is downregulated in MIX grey matter with impaired neurogenesis. 
Collectively, major membrane component lipids are coordinately affirming the 
integrity of plasma membrane and playing different roles during neural 
development. The coordination of these lipids might regulate the proliferation 
and differentiation of NSCs, neuronal growth, and be involved in pathological 
conditions in dementia. Specifically, the reciprocal regulation between PC and 
ChoL might be a key factor in neurogenesis yet underlying mechanisms have 
not been understood so far. 
 
5.3 Bioactive lipids in neural development 
In addition to being the major component in membranes and energy 
metabolism, lipids are also considered as bioactive signaling molecules. Cer 
and its derivatives are involved in several essential signalling pathways 
regulating the cell survival, proliferation, differentiation and polarization. The 
proposed lipid metabolism network in NSCs shows a dominant decrease in 
bioactive sphingolipids, including Cer, GluCer, SL and probably gangliosides. 
The downregulation of Cer and its derivatives during the NSC-enrichment of 
neurospheres implied that these lipids are likely to be accumulated and more 
active during the differentiation instead of self-renewal in NSCs, and tend to 
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push NSCs into differentiated state (Chapter 2). Indeed, neuronal 
differentiation can be promoted by Cer analog [308], and different 
gangliosides are required for distinct NSCs differentiation stages specifically 
[111]. A chain-length specific reduction of C16-C18-Cer is observed in 
astrocytes comparing to neurons in parellel with a decrease in corresponding 
GluCer, whereas C24-Cer is increased. Cell proliferation can be specifically 
promoted by C24 Cer [235], yet C16-C18 Cer exhibited an anti-proliferative 
effect [240]. Thus, the chain length dependent alterations in Cer suggested a 
higher proliferative ability of astrocytes compared to neurons (Chapter 3). 
Appreciable alterations in Cer and its derivatives are also found in the SIVD 
and MIX patients brain (Chapter 4). Specifically, the chain length specific 
alterations of Cer and SM in SIVD are in accord with CerS2-null mice model, 
which exhibits reduced C22-C24-Cer and C22-C24-SM accompanied by 
concomitant increases in C18-Cer and C18-SM with an overall reduction in 
GalCer. Myelin degeneration and detachment from axons without appreciable 
neuronal loss, coupled with motor dysfunction are observed in this mice 
model [286], aligned with the major neuropathological and clinical 
manifestations of SIVD [275]. Besides, the augmented amounts of VLC-GM3 
in MIX grey matter might be detrimental to AD pathogenesis [297], as the 
longer fatty acyl chain GM3 with stronger hydrophobic forces intend to form 
ganglioside-enriched membrane clusters that have been shown to be involved 
in seeding A! polymerization [296, 298]. Interestingly, the chain length 
specific alterations of Cer in SIVD white matter (Chapter 4) are in parallel 
with what is observed in glial cells (Chapter 3). The accumulation of C24-Cer 
concomitant with the reduction of C16-C18-Cer in glial cells implied that 
C24-Cer specifically promotes the proliferation of glial cells yet C18-Cer 
might have an opposite effect reciprocally. Thus, the disruption of myelin 
integrity in SIVD could be due to the compromised proliferation in glial cells 
resulting from the reduction of C24-Cer accompanied with the increased of 
C16-C18-Cer. 
Collectively, Cer and its downstream derivatives are most likely to regulate 
the proliferation of NSCs and differentiated neural cells, and consequently 
contribute to the pathogenesis of SIVD. This modulating effect is possibly 
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fatty acyl chain length dependent, yet underlying mechanisms need to be 
further illustrated. 
 
5.4 Endosome-mediated trafficking in neural development 
LBPA is localized exclusively within the internal membranes of late 
endosomes. This unconventional phospholipid has been implicated in 
specifically sorting lipids either for lysosomal degradation or plasma 
membrane recycling [212]. The early increase of LBPA during the NSC-
enrichment in neurospheres might be related with the massive cell death of 
progenitors and differentiated cells at the early stage of neurosphere culture 
(Chapter 2). Differentiated neural cells also exhibit alterations in LBPA 
(Chapter 3). The specific accumulation of LBPA in astrocytes from the co-
culture system rather than the glial culture system is highly possible correlated 
with the ChoL transportation between astrocytes and neurons. Astrocyte has a 
higher rate of ChoL synthesis [131], and the excess ChoL in astrocyte is 
transferred into neurons via endosome-mediated trafficking to fulfill the need 
of ChoL for neuronal growth. On the other hand, the parallel upregulation in 
LBPA and its potential precursor PG suggest the involvement of these two 
lipids in axon and dendrite formation. It is likely that LBPA-enriched 
endosome is involved in temporal and spatial distribution of membrane 
proteins during the neuronal growth, and the membrane polarization is crucial 
during the neuronal growth (Chapter 3). Moreover, the global accumulation of 
LBPA in MIX grey matter is in line with the endolysosomal dysfunction 
theory for AD pathogenesis [292], which is further conferred by the drastic 
accumulation of LBPA (Chapter 4). 
Therefore, LBPA-enriched endosome might play important roles in neural 
development. Its regulating effect may vary upon the cell types and 
developmental stages. The lipids and proteins trafficking between intracellular 
organelles and cell membranes or between different types of neural cells are 
highly possible to affect the signal transduction, and further regulate the 
downstream signaling pathways that are responsible for normal neural 
development or neurological disease. 
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6. Conclusion and future work 
6.1 Conclusion 
In this study, we have established lipid profiles in 1) NSCs; 2) neurons at 
different developmental stages and astrocytes; 3) the white and grey matter 
from the SIVD and MIX patients brain with age/gender-matched controls. 
These lipidomics studies revealed the lipid composition and metabolism in 
different types of neural cells and brain tissues, suggesting the crucial roles of 
lipids in NSCs proliferation, differentiation, neuronal growth and pathogenesis 
of dementia. The correlation between lipid profiles at cellular basis (NSCs and 
differentiated cells) and under pathological conditions (SIVD and MIX) would 
help understand the pathogenesis of dementia at the cellular level. 
Degree of fatty acyls unsaturation, plasmalogen lipids and lipid oxidation are 
essential factors in modulating the redox state during neural development, and 
further regulate the cellular functions. Increased unsaturation of fatty acyls 
maintains NSCs in an undifferentiated state instead of going through 
differentiation. When NSCs differentiate into fate-specific neural cells, the 
accumulation of plasmalogen lipids in astrocytes accommodate its higher 
proliferative ability against oxidative stress. Moreover, the “remote ischemic 
preconditioning” implied by increased unsaturation in fatty acyls might work 
as a defensive mechanism in the peri-ischemic area in SIVD. Notably, the 
similar redox state in NSCs and SIVD white matter might suggest the increase 
of neural precursors in SIVD, affirming the correlation between neurogenesis 
and this type of dementia. 
Another essential function of lipids is to constitute the plasma membrane. 
Major membrane component lipids, especially PC, ChoL and SM, are 
coordinately affirming the integrity of plasma membrane and playing different 
roles during neural development. PC is closely regulated with sterols in NSCs. 
The accumulation in PC is accompanied by the reciprocal decrease of ChoL 
and probably required for NSCs self-renewal, whereas the opposite alterations 
may facilitate differentiation and sequential neuronal growth. Membranes lipid 
aberrations also contribute to the pathogenesis in dementia especially MIX, 
which is probably lipid raft related. 
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Sphingolipids, namely Cer and its derivatives are known as bioactive 
molecules involved in numerous signaling pathways. The dominant decrease 
of these lipids might be responsible for maintaining the self-renewal of NSCs. 
Interestingly, the fatty acyl chain length dependent alterations of Cer and 
GluCer in cultured glial cells are comparable with the observation in SIVD 
white matter, suggesting that the reciprocal changes in C24-Cer and C18-Cer 
are crucial in glial cell proliferation that is responsible for the myelin integrity 
in the brain. 
Moreover, endosome-mediated trafficking seems to be a universal event 
during neural development. LBPA is exclusively localized in late endosome. 
The effect of LBPA-enriched endosome may depend on the cell types and 
developmental stages. With the involvement of endosome, the lipids and 
proteins trafficking between intracellular organelles and cell membranes or 
between different types of neural cells is highly possible to affect the signal 
transduction, and further regulating the downstream signaling pathways that 
are responsible for normal neural development or neurodegenerative diseases. 
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6.2 Future work 
The comprehensive lipidomics studies provide a general idea of the lipid 
metabolism during neural development, and unmask some potential effects of 
lipids in these biological events. However, more investigations are required to 
clarify the functions of lipids in these processes. 
Our lipidomics study is based on whole cell lipid extraction, which may lose 
the spatial information  of lipids during neural development. Subcellular lipid 
extraction could be employed to unveil more details about lipid localization 
and dynamic distribution. Alternatively, another newly emerging technology, 
MS-imaging could also be utilized. This technique allows scientists to detect 
lipids in situ, which retains the spatial information of the lipids, but at the 
expense of sensitivity and specificity. 
Specifically, fatty acid desaturase could be a potential target to control the 
degree of lipid unsaturation, which modulates the redox state in neural cells. 
Besides, suppressing/enhancing plasmalogen biosynthesis could be performed 
to test the susceptibility of astrocytes and neurons against oxidation, and 
further balance the proliferation of glial cells and functional neurons under 
oxidative stress related injury and disease. 
Fatty acyl chain-length dependent effect of Cer in glial cells proliferation 
suggested by in vitro cell culture could be verified by inhibiting/activating 
chain-length specific Cer synthase (e.g. CerS1-6). Moreover, our results 
indicate that CerS2-null mice could be a potentially relevant model for human 
SIVD. 
Intensive research has been addressed in endosomal functions during the 
neural development. However, little evidence elucidate how LBPA interacts 
with endosomal proteins, or the mannaer in which this LBPA-protein complex 
modulates cellular signaling. Hence it would be interesting to investigate the 
roles of LBPA in endosome involved cellular trafficking during neural 
development. 
Notably, most of the lipid profiles analyzed are based on in vitro assays. 
Although these assays have been established for decades and validated by 
different studies, it is still controversial whether the in vivo conditions and 
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properties can be truly elucidated via in vitro approaches. Therefore, more in 
vivo studies are required to validate the hypothesis mentioned above. 
In summary, the comprehensive lipid profiles establish a consolidated base for 
future research to elucidate the underlying lipid-related mechanisms during 
neural development, and suggest several promising directions in this field. 
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Appendices 
 
Supplementary Table S1. Overview of MRM list used in each study. 
Lipid Name Chapter 2 Chapter 3 Chapter 4 
SM18:1/16:0 ✓ ✓ ✓ 
SM18:0/16:0 ✓ ✓ ✓ 
SM18:1/18:1 ✓ ✓ ✓ 
SM18:1/18:0 ✓ ✓ ✓ 
SM18:1/20:1 ✓ ✓ ✓ 
SM18:1/20:0 ✓ ✓ ✓ 
SM18:1/22:1 ✓ ✓ ✓ 
SM18:1/22:0 ✓ ✓ 
 SM18:1/24:1 ✓ ✓ 






















Cer d18:1/19:0 ✓ ✓ 
 Cer d18:1/16:0 ✓ ✓ ✓ 
Cer d18:1/18:0 ✓ ✓ ✓ 
Cer d18:0/18:0 ✓ ✓ 
 Cer d18:1/20:0 ✓ ✓ ✓ 
Cer d18:1/22:0 ✓ ✓ ✓ 
Cer d18:1/24:1 ✓ ✓ ✓ 
Cer d18:1/24:0 ✓ ✓ ✓ 
















GluCer d18:1/16:0 ✓ ✓ ✓ 
GluCer d18:1/18:0 ✓ ✓ ✓ 
GluCer d18:1/20:0 ✓ ✓ ✓ 
GluCer d18:1/22:0 ✓ ✓ ✓ 
GluCer d18:1/24:1 ✓ ✓ ✓ 
GluCer d18:1/24:0 ✓ ✓ ✓ 




























































  SL d18:1/22:1 ✓ ✓ ✓ 
SL d18:1/22:0 ✓ ✓ ✓ 
SL d18:1/24:1 ✓ ✓ ✓ 
SL d18:1/24:0 ✓ ✓ ✓ 
SL d18:1/24:1h ✓ ✓ ✓ 



































































PC32:1e, 32:0p ✓ ✓ ✓ 
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PC32:0e ✓ ✓ 
 PC32:2 ✓ ✓ ✓ 
PC32:1 ✓ ✓ ✓ 
PC32:0 ✓ ✓ ✓ 
PC34:3e,34:2p ✓ ✓ 
 PC34:2e,34:1p ✓ ✓ ✓ 
PC34:1e,34:0p ✓ ✓ ✓ 
PC34:3 ✓ ✓ ✓ 
PC34:2 ✓ ✓ ✓ 
PC34:1 ✓ ✓ ✓ 
PC36:5e, 36:4p ✓ ✓ ✓ 
PC36:4e, 36:3p ✓ ✓ ✓ 
PC36:3e, 36:2p ✓ ✓ ✓ 
PC36:2e, 36:1p ✓ ✓ ✓ 
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Supplementary Table S4-1. Detailed demographic and disease variables in a 
cohort of control and dementia patients.  
 
Age at Death Sex 
Postmortem 
Interval 
 Group (years) (Male/Female) (hours) Cohort 
Control 68 F 75 Newcastle II 
Control 78 F 23 Newcastle II 
Control 72 M 17 Newcastle II 
Control 75 M 20 Newcastle II 
Control 82 F 26 Newcastle II 
Control 87 F 14 Newcastle II 
Control 99 F 19 Newcastle II 
Control 86 F 40 Newcastle II 
Control 75 F 31 Newcastle II 
Control 81 F 51 Newcastle II 
Control 68 M 54 Newcastle 
Control 82 M 36 Newcastle 
Control 80 M 48 BDR 
Control 85 M 42 BDR 
SIVD 75 M 24 Newcastle II 
SIVD 93 M 32 Newcastle II 
SIVD 82 M 19 Newcastle II 
SIVD 88 F 71 Newcastle II 
SIVD 96 M 45 Newcastle II 
SIVD 81 M 24 Newcastle II 
SIVD 84 M . Newcastle II 
SIVD 86 F 41 Newcastle II 
SIVD 67 F 130 Newcastle II 
SIVD 88 M . Newcastle II 
SIVD 98 F 17 Newcastle 
MIX 93 F 18 Newcastle II 
MIX 83 M 71 Newcastle II 
MIX 72 M 29 Newcastle II 
MIX 84 M 42 Newcastle II 
MIX 89 F 72 Newcastle II 
MIX 89 F 32 Newcastle II 
MIX 92 F 12 Newcastle II 
MIX 86 F 99 Newcastle II 
MIX 82 M 38 Newcastle II 
MIX 64 M 24 Newcastle II 
BDR, Brains for Dementia Research Project; MIX, mixed dementia (SIVD / Alzheimer’s 
disease); SIVD, subcortical ischemic vascular dementia. 
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Supplementary Figure S4-1. Comparison on the degree of unsaturation of plasmalogen 
PE in the white matter and grey matter. ***p<0.001. 
 
Supplementary Fig. S1. 
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Supplementary Figure S4-2. Heatmaps illustrating the alterations in global lipid profiles 
of white matter in MIX and SIVD compared to controls. Z-scores were plotted and 
statistically significant results from One-way ANOVA with post-hoc Dunnett’s test were 
marked. The correction of multiple comparisons was done by controlling the false discovery 
rate using the q value. #p<0.10, *p<0.05, **p<0.01, **p<0.001. 
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Supplementary Figure S4-3. Heatmaps illustrating the alterations in global lipid profiles 
of grey matter in MIX and SIVD compared to controls. Z-scores were plotted and 
statistically significant results from One-way ANOVA with post-hoc Dunnett’s test were 
marked. The correction of multiple comparisons was done by controlling the false discovery 
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Supplementary Figure S4-4. Comparison of the abundance and unsaturation degree of 
PE in the white matter and grey matter of control, SIVD and MIX. Comparison of the 
amounts of total plasmalogen PE and diacyl-PE  in the (A) white matter and (B) grey matter 
of control, SIVD and MIX. Comparison of the changes in the degree of unsaturation of 
plasmalogen PE in the (C) white matter and (D) grey matter of control, SIVD and MIX. 
 
Supplementary Fig. S4. 
Comparison of the levels of total plasmalogen PE and diacyl-PE in the (A) white matter and (B) 
grey matter of control, SIVD and MIX. Comparison of the changes in the degree of unsaturation of 
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Comparison of the levels of total plasmalogen PE and diacyl-PE in the (A) white matter and (B) 
grey matter of control, SIVD and MIX. Comparison of the changes in the degree of unsaturation of 






















1 2 3  




































A                                                                      B 




Degree of unsaturation Degree of unsaturation 
Supplementary Fig. S4. 
Comparison of the levels of total plasmalogen PE and diacyl-PE in the (A) white matter and (B) 
grey matter of control, SIVD and MIX. Comparison of the changes in the degree of unsaturation of 
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